{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:54:22Z","timestamp":1793656462154,"version":"4.5.1"},"reference-count":306,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T00:00:00Z","timestamp":1746835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Special Project for Performance Incentive Guidance of Scientific Research Institutions","award":["2024JXJL-YFX0022"],"award-info":[{"award-number":["2024JXJL-YFX0022"]}]},{"name":"the Natural Science Foundation of Chongqing, China","award":["CSTB2022NSCQ-MSX1150"],"award-info":[{"award-number":["CSTB2022NSCQ-MSX1150"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["2022CDJYGRH-001"],"award-info":[{"award-number":["2022CDJYGRH-001"]}]},{"name":"the Chongqing Professional Talents Plan","award":["cstc2022ycjh-bgzxm0048"],"award-info":[{"award-number":["cstc2022ycjh-bgzxm0048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Hematol Oncol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Haematological malignancies are one of the most common tumors, with a rising incidence noted over recent decades. Viral infections play significant roles in the pathogenesis of these malignancies globally. This review delves into the contributions of various known viruses\u2014specifically Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), human T-cell leukemia virus type 1 (HTLV-1), Kaposi\u2019s sarcoma-associated herpesvirus (KSHV), human cytomegalovirus (HCMV), hepatitis B virus (HBV), hepatitis C virus (HCV), and human papillomavirus (HPV)\u2014in the development of haematological malignancies. These viruses are shown to drive tumorigenesis through mechanisms, such as metabolic reprogramming, epigenetic modifications, and remodeling of the immune microenvironment. By directly disrupting fundamental cellular functions and altering metabolic and epigenetic pathways, these viruses foster an immune milieu that supports both viral persistence and tumor growth. A thorough understanding of these viral oncogenic processes is crucial not only for etiological discovery but also for developing targeted interventions. This review emphasizes the need for continued research into the specific ways these viruses manipulate the host cell\u2019s metabolic and epigenetic environments, aiming to provide insights that could guide future advancements in treatment modalities.<\/jats:p>","DOI":"10.1186\/s40164-025-00655-2","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T07:00:31Z","timestamp":1746860431000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Molecular mechanisms of viral oncogenesis in haematological malignancies: perspectives from metabolic reprogramming, epigenetic regulation and immune microenvironment remodeling"],"prefix":"10.1186","volume":"14","author":[{"given":"Qing","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejiao","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanxiu","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,10]]},"reference":[{"issue":"12","key":"655_CR1","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrc2961","volume":"10","author":"PS Moore","year":"2010","unstructured":"Moore PS, Chang Y. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer. 2010;10(12):878\u201389.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"655_CR2","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S1470-2045(09)70096-8","volume":"10","author":"V Bouvard","year":"2009","unstructured":"Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens--Part B: biological agents. Lancet Oncol. 2009;10(4):321\u20132.","journal-title":"Lancet Oncol"},{"issue":"4","key":"655_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/S1470-2045(12)70125-0","volume":"13","author":"V Bouvard","year":"2012","unstructured":"Bouvard V, Baan RA, Grosse Y, Lauby-Secretan B, El Ghissassi F, Benbrahim-Tallaa L, et al. Carcinogenicity of malaria and of some polyomaviruses. Lancet Oncol. 2012;13(4):339\u201340.","journal-title":"Lancet Oncol"},{"issue":"7015","key":"655_CR4","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/nature03100","volume":"432","author":"PA Beachy","year":"2004","unstructured":"Beachy PA, Karhadkar SS, Berman DM. Tissue repair and stem cell renewal in carcinogenesis. Nature. 2004;432(7015):324\u201331.","journal-title":"Nature"},{"key":"655_CR5","doi-asserted-by":"crossref","unstructured":"Hatano Y, Fukuda S, Hisamatsu K, Hirata A, Hara A, Tomita H. Multifaceted interpretation of Colon cancer stem cells. Int J Mol Sci. 2017;18(7).","DOI":"10.3390\/ijms18071446"},{"issue":"1","key":"655_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s13578-021-00688-0","volume":"11","author":"T Li","year":"2021","unstructured":"Li T, Gao SJ. Metabolic reprogramming and metabolic sensors in KSHV-induced cancers and KSHV infection. Cell Bioscience. 2021;11(1):176.","journal-title":"Cell Bioscience"},{"issue":"8","key":"655_CR7","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.3324\/haematol.2019.225953","volume":"105","author":"Y Saito","year":"2020","unstructured":"Saito Y, Sawa D, Kinoshita M, Yamada A, Kamimura S, Suekane A, et al. EVI1 triggers metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase. Haematologica. 2020;105(8):2118\u201329.","journal-title":"Haematologica"},{"key":"655_CR8","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3389\/fmicb.2018.01233","volume":"9","author":"PP Piccaluga","year":"2018","unstructured":"Piccaluga PP, Weber A, Ambrosio MR, Ahmed Y, Leoncini L. Epstein-Barr Virus-Induced metabolic rearrangements in human B-Cell lymphomas. Front Microbiol. 2018;9:1233.","journal-title":"Front Microbiol"},{"key":"655_CR9","doi-asserted-by":"crossref","unstructured":"Soliman SHA, Orlacchio A, Verginelli F. Viral manipulation of the host epigenome as a driver of Virus-Induced oncogenesis. Microorganisms. 2021;9(6).","DOI":"10.3390\/microorganisms9061179"},{"key":"655_CR10","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2015.04.006","volume":"34","author":"R Dolcetti","year":"2015","unstructured":"Dolcetti R. Cross-talk between Epstein-Barr virus and microenvironment in the pathogenesis of lymphomas. Sem Cancer Biol. 2015;34:58\u201369.","journal-title":"Sem Cancer Biol"},{"issue":"1","key":"655_CR11","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/COH.0000000000000333","volume":"12","author":"A Carbone","year":"2017","unstructured":"Carbone A, Volpi CC, Gualeni AV, Gloghini A. Epstein-Barr virus associated lymphomas in people with HIV. Curr Opin HIV AIDS. 2017;12(1):39\u201346.","journal-title":"Curr Opin HIV AIDS"},{"key":"655_CR12","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1146\/annurev-immunol-032414-112326","volume":"33","author":"GS Taylor","year":"2015","unstructured":"Taylor GS, Long HM, Brooks JM, Rickinson AB, Hislop AD. The immunology of Epstein-Barr virus-induced disease. Annu Rev Immunol. 2015;33:787\u2013821.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"655_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10014-011-0020-x","volume":"28","author":"S Utsuki","year":"2011","unstructured":"Utsuki S, Oka H, Miyajima Y, Kijima C, Yasui Y, Fujii K. Epstein-Barr virus (EBV)-associated primary central nervous system lymphoma: is incidence of EBV expression associated with median survival time? Brain Tumor Pathol. 2011;28(2):145\u20139.","journal-title":"Brain Tumor Pathol"},{"issue":"5","key":"655_CR14","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/nrmicro2548","volume":"9","author":"SA Connolly","year":"2011","unstructured":"Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. Fusing structure and function: a structural view of the herpesvirus entry machinery. Nat Rev Microbiol. 2011;9(5):369\u201381.","journal-title":"Nat Rev Microbiol"},{"issue":"15","key":"655_CR15","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1128\/JVI.00445-07","volume":"81","author":"LM Hutt-Fletcher","year":"2007","unstructured":"Hutt-Fletcher LM. Epstein-Barr virus entry. J Virol. 2007;81(15):7825\u201332.","journal-title":"J Virol"},{"key":"655_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coviro.2013.12.001","volume":"4","author":"C Shannon-Lowe","year":"2014","unstructured":"Shannon-Lowe C, Rowe M. Epstein barr virus entry; kissing and conjugation. Curr Opin Virol. 2014;4:78\u201384.","journal-title":"Curr Opin Virol"},{"issue":"23","key":"655_CR17","doi-asserted-by":"publisher","first-page":"15036","DOI":"10.1073\/pnas.232381299","volume":"99","author":"B Neuhierl","year":"2002","unstructured":"Neuhierl B, Feederle R, Hammerschmidt W, Delecluse HJ. Glycoprotein gp110 of Epstein-Barr virus determines viral tropism and efficiency of infection. Proc Natl Acad Sci U S A. 2002;99(23):15036\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"655_CR18","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1007\/s00018-008-7570-z","volume":"65","author":"EE Heldwein","year":"2008","unstructured":"Heldwein EE, Krummenacher C. Entry of herpesviruses into mammalian cells. Cell Mol Life Sci. 2008;65(11):1653\u201368.","journal-title":"Cell Mol Life Sci"},{"issue":"16","key":"655_CR19","doi-asserted-by":"publisher","first-page":"5027","DOI":"10.1128\/MCB.00194-08","volume":"28","author":"O Ikeda","year":"2008","unstructured":"Ikeda O, Sekine Y, Yasui T, Oritani K, Sugiyma K, Muromoto R, et al. STAP-2 negatively regulates both canonical and noncanonical NF-kappaB activation induced by Epstein-Barr virus-derived latent membrane protein 1. Mol Cell Biol. 2008;28(16):5027\u201342.","journal-title":"Mol Cell Biol"},{"key":"655_CR20","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","volume":"25","author":"AD Hislop","year":"2007","unstructured":"Hislop AD, Taylor GS, Sauce D, Rickinson AB. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu Rev Immunol. 2007;25:587\u2013617.","journal-title":"Annu Rev Immunol"},{"issue":"7","key":"655_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1056\/NEJM200008173430707","volume":"343","author":"JI Cohen","year":"2000","unstructured":"Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000;343(7):481\u201392.","journal-title":"N Engl J Med"},{"issue":"3","key":"655_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.coviro.2013.04.005","volume":"3","author":"DA Thorley-Lawson","year":"2013","unstructured":"Thorley-Lawson DA, Hawkins JB, Tracy SI, Shapiro M. The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol. 2013;3(3):227\u201332.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"655_CR23","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","volume":"24","author":"OA Odumade","year":"2011","unstructured":"Odumade OA, Hogquist KA, Balfour HH Jr. Progress and problems in Understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev. 2011;24(1):193\u2013209.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"655_CR24","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cmet.2019.06.003","volume":"30","author":"LW Wang","year":"2019","unstructured":"Wang LW, Shen H, Nobre L, Ersing I, Paulo JA, Trudeau S, et al. Epstein-Barr-Virus-Induced One-Carbon metabolism drives B cell transformation. Cell Metab. 2019;30(3):539\u2013e5511.","journal-title":"Cell Metab"},{"issue":"6155","key":"655_CR25","doi-asserted-by":"publisher","first-page":"1242454","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce EL, Poffenberger MC, Chang CH, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342(6155):1242454.","journal-title":"Science"},{"issue":"8","key":"655_CR26","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41590-018-0156-5","volume":"19","author":"M Akkaya","year":"2018","unstructured":"Akkaya M, Traba J, Roesler AS, Miozzo P, Akkaya B, Theall BP, et al. Second signals rescue B cells from activation-induced mitochondrial dysfunction and death. Nat Immunol. 2018;19(8):871\u201384.","journal-title":"Nat Immunol"},{"key":"655_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1073\/pnas.2022495118","volume":"118","author":"EN Bonglack","year":"2021","unstructured":"Bonglack EN, Messinger JE, Cable JM, Ch\u2019ng J, Parnell KM, Reinoso-Vizca\u00edno NM, et al. Monocarboxylate transporter antagonism reveals metabolic vulnerabilities of viral-driven lymphomas. Proc Natl Acad Sci U S A. 2021;118:25.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"655_CR28","doi-asserted-by":"publisher","first-page":"E782","DOI":"10.1073\/pnas.1517141113","volume":"113","author":"K McFadden","year":"2016","unstructured":"McFadden K, Hafez AY, Kishton R, Messinger JE, Nikitin PA, Rathmell JC, et al. Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization. Proc Natl Acad Sci U S A. 2016;113(6):E782\u201390.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"655_CR29","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.1158\/0008-5472.CAN-11-1715","volume":"71","author":"TG Sommermann","year":"2011","unstructured":"Sommermann TG, O\u2019Neill K, Plas DR, Cahir-McFarland E. IKK\u03b2 and NF-\u03baB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1. Cancer Res. 2011;71(23):7291\u2013300.","journal-title":"Cancer Res"},{"issue":"7","key":"655_CR30","doi-asserted-by":"publisher","first-page":"e42072","DOI":"10.1371\/journal.pone.0042072","volume":"7","author":"S Darekar","year":"2012","unstructured":"Darekar S, Georgiou K, Yurchenko M, Yenamandra SP, Chachami G, Simos G, et al. Epstein-Barr virus immortalization of human B-cells leads to stabilization of hypoxia-induced factor 1 alpha, congruent with the Warburg effect. PLoS ONE. 2012;7(7):e42072.","journal-title":"PLoS ONE"},{"issue":"5","key":"655_CR31","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/ncb1724","volume":"10","author":"K Kawauchi","year":"2008","unstructured":"Kawauchi K, Araki K, Tobiume K, Tanaka N. p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol. 2008;10(5):611\u20138.","journal-title":"Nat Cell Biol"},{"issue":"23","key":"655_CR32","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1182\/blood-2009-10-249540","volume":"115","author":"CM Krawczyk","year":"2010","unstructured":"Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115(23):4742\u20139.","journal-title":"Blood"},{"issue":"1","key":"655_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.canlet.2016.08.021","volume":"382","author":"WW Sung","year":"2016","unstructured":"Sung WW, Chu YC, Chen PR, Liao MH, Lee JW. Positive regulation of HIF-1A expression by EBV oncoprotein LMP1 in nasopharyngeal carcinoma cells. Cancer Lett. 2016;382(1):21\u201331.","journal-title":"Cancer Lett"},{"issue":"3","key":"655_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/path.4201","volume":"230","author":"AK Lo","year":"2013","unstructured":"Lo AK, Lo KW, Ko CW, Young LS, Dawson CW. Inhibition of the LKB1-AMPK pathway by the Epstein-Barr virus-encoded LMP1 promotes proliferation and transformation of human nasopharyngeal epithelial cells. J Pathol. 2013;230(3):336\u201346.","journal-title":"J Pathol"},{"issue":"8","key":"655_CR35","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1002\/ijc.30795","volume":"141","author":"AK Lo","year":"2017","unstructured":"Lo AK, Dawson CW, Young LS, Lo KW. The role of metabolic reprogramming in \u03b3-herpesvirus-associated oncogenesis. Int J Cancer. 2017;141(8):1512\u201321.","journal-title":"Int J Cancer"},{"issue":"2","key":"655_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12250-015-3599-y","volume":"30","author":"GG Luo","year":"2015","unstructured":"Luo GG, Ou JH. Oncogenic viruses and cancer. Virol Sin. 2015;30(2):83\u20134.","journal-title":"Virol Sin"},{"key":"655_CR37","doi-asserted-by":"crossref","unstructured":"Saha A, Robertson ES. Mechanisms of B-Cell oncogenesis induced by Epstein-Barr virus. J Virol. 2019;93(13).","DOI":"10.1128\/JVI.00238-19"},{"key":"655_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.coviro.2018.08.012","volume":"32","author":"TC Frost","year":"2018","unstructured":"Frost TC, Gewurz BE. Epigenetic crossroads of the Epstein-Barr virus B-cell relationship. Curr Opin Virol. 2018;32:15\u201323.","journal-title":"Curr Opin Virol"},{"issue":"11","key":"655_CR39","doi-asserted-by":"publisher","first-page":"e2118300119","DOI":"10.1073\/pnas.2118300119","volume":"119","author":"EM Burton","year":"2022","unstructured":"Burton EM, Voyer J, Gewurz BE. Epstein-Barr virus latency programs dynamically sensitize B cells to ferroptosis. Proc Natl Acad Sci U S A. 2022;119(11):e2118300119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"655_CR40","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.cmet.2022.02.011","volume":"34","author":"K Kudo","year":"2022","unstructured":"Kudo K, Miki Y, Carreras J, Nakayama S, Nakamoto Y, Ito M, et al. Secreted phospholipase A(2) modifies extracellular vesicles and accelerates B cell lymphoma. Cell Metab. 2022;34(4):615\u2013e338.","journal-title":"Cell Metab"},{"issue":"751","key":"655_CR41","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1259\/0007-1285-63-751-542","volume":"63","author":"P Loverock","year":"1990","unstructured":"Loverock P, ter Haar G, Ormerod MG, Imrie PR. The effect of ultrasound on the cytotoxicity of adriamycin. Br J Radiol. 1990;63(751):542\u20136.","journal-title":"Br J Radiol"},{"issue":"47","key":"655_CR42","doi-asserted-by":"publisher","first-page":"36267","DOI":"10.1074\/jbc.M110.141606","volume":"285","author":"F Morrish","year":"2010","unstructured":"Morrish F, Noonan J, Perez-Olsen C, Gafken PR, Fitzgibbon M, Kelleher J, et al. Myc-dependent mitochondrial generation of acetyl-CoA contributes to fatty acid biosynthesis and histone acetylation during cell cycle entry. J Biol Chem. 2010;285(47):36267\u201374.","journal-title":"J Biol Chem"},{"issue":"4","key":"655_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2013-07-517649","volume":"123","author":"K Fish","year":"2014","unstructured":"Fish K, Chen J, Longnecker R. Epstein-Barr virus latent membrane protein 2A enhances MYC-driven cell cycle progression in a mouse model of B lymphoma. Blood. 2014;123(4):530\u201340.","journal-title":"Blood"},{"issue":"1","key":"655_CR44","doi-asserted-by":"publisher","first-page":"e1009208","DOI":"10.1371\/journal.ppat.1009208","volume":"17","author":"RJ Lamontagne","year":"2021","unstructured":"Lamontagne RJ, Soldan SS, Su C, Wiedmer A, Won KJ, Lu F, et al. A multi-omics approach to Epstein-Barr virus immortalization of B-cells reveals EBNA1 chromatin pioneering activities targeting nucleotide metabolism. PLoS Pathog. 2021;17(1):e1009208.","journal-title":"PLoS Pathog"},{"issue":"32","key":"655_CR45","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1073\/pnas.1901314116","volume":"116","author":"P Mrozek-Gorska","year":"2019","unstructured":"Mrozek-Gorska P, Buschle A, Pich D, Schwarzmayr T, Fechtner R, Scialdone A, et al. Epstein-Barr virus reprograms human B lymphocytes immediately in the prelatent phase of infection. Proc Natl Acad Sci U S A. 2019;116(32):16046\u201355.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"655_CR46","doi-asserted-by":"publisher","first-page":"e1008030","DOI":"10.1371\/journal.ppat.1008030","volume":"15","author":"LW Wang","year":"2019","unstructured":"Wang LW, Wang Z, Ersing I, Nobre L, Guo R, Jiang S, et al. Epstein-Barr virus subverts mevalonate and fatty acid pathways to promote infected B-cell proliferation and survival. PLoS Pathog. 2019;15(9):e1008030.","journal-title":"PLoS Pathog"},{"key":"655_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1101\/sqb.2016.81.031153","volume":"81","author":"CV Dang","year":"2016","unstructured":"Dang CV. A time for MYC: metabolism and therapy. Cold Spring Harb Symp Quant Biol. 2016;81:79\u201383.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"issue":"13","key":"655_CR48","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1016\/j.celrep.2017.12.002","volume":"21","author":"M Yue","year":"2017","unstructured":"Yue M, Jiang J, Gao P, Liu H, Qing G. Oncogenic MYC activates a feedforward regulatory loop promoting essential amino acid metabolism and tumorigenesis. Cell Rep. 2017;21(13):3819\u201332.","journal-title":"Cell Rep"},{"issue":"9","key":"655_CR49","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1016\/j.cmet.2022.08.008","volume":"34","author":"R Guo","year":"2022","unstructured":"Guo R, Liang JH, Zhang Y, Lutchenkov M, Li Z, Wang Y, et al. Methionine metabolism controls the B cell EBV epigenome and viral latency. Cell Metab. 2022;34(9):1280\u2013e979.","journal-title":"Cell Metab"},{"issue":"4","key":"655_CR50","doi-asserted-by":"publisher","first-page":"e0153021","DOI":"10.1128\/mBio.01530-21","volume":"12","author":"JH Liang","year":"2021","unstructured":"Liang JH, Wang C, Yiu SPT, Zhao B, Guo R, Gewurz BE. Epstein-Barr virus induced cytidine metabolism roles in transformed B-Cell growth and survival. mBio. 2021;12(4):e0153021.","journal-title":"mBio"},{"key":"655_CR51","doi-asserted-by":"crossref","unstructured":"Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y et al. RNA sequencing analyses of gene expression during Epstein-Barr virus infection of primary B lymphocytes. J Virol. 2019;93(13).","DOI":"10.1128\/JVI.00226-19"},{"issue":"2","key":"655_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","volume":"171","author":"BR Stockwell","year":"2017","unstructured":"Stockwell BR, Friedmann Angeli JP, Bayir H, Bush AI, Conrad M, Dixon SJ, et al. Ferroptosis: A regulated cell death Nexus linking metabolism, redox biology, and disease. Cell. 2017;171(2):273\u201385.","journal-title":"Cell"},{"issue":"7","key":"655_CR53","doi-asserted-by":"publisher","first-page":"2766","DOI":"10.1158\/0008-5472.CAN-08-3070","volume":"69","author":"R Hino","year":"2009","unstructured":"Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, et al. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res. 2009;69(7):2766\u201374.","journal-title":"Cancer Res"},{"key":"655_CR54","doi-asserted-by":"crossref","unstructured":"Hatano Y, Ideta T, Hirata A, Hatano K, Tomita H, Okada H et al. Virus-Driven Carcinog Cancers (Basel). 2021;13(11).","DOI":"10.3390\/cancers13112625"},{"issue":"6","key":"655_CR55","doi-asserted-by":"publisher","first-page":"e1000492","DOI":"10.1371\/journal.ppat.1000492","volume":"5","author":"K Paschos","year":"2009","unstructured":"Paschos K, Smith P, Anderton E, Middeldorp JM, White RE, Allday MJ. Epstein-barr virus latency in B cells leads to epigenetic repression and CpG methylation of the tumour suppressor gene Bim. PLoS Pathog. 2009;5(6):e1000492.","journal-title":"PLoS Pathog"},{"issue":"2","key":"655_CR56","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3390\/pathogens1020083","volume":"1","author":"K Vrzalikova","year":"2012","unstructured":"Vrzalikova K, Leonard S, Fan Y, Bell A, Vockerodt M, Flodr P, et al. Hypomethylation and Over-Expression of the Beta isoform of BLIMP1 is induced by Epstein-Barr virus infection of B cells; potential implications for the pathogenesis of EBV-Associated lymphomas. Pathogens. 2012;1(2):83\u2013101.","journal-title":"Pathogens"},{"issue":"1","key":"655_CR57","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1038\/emm.2014.84","volume":"47","author":"MS Kang","year":"2015","unstructured":"Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med. 2015;47(1):e131.","journal-title":"Exp Mol Med"},{"key":"655_CR58","doi-asserted-by":"crossref","unstructured":"Wood CD, Veenstra H, Khasnis S, Gunnell A, Webb HM, Shannon-Lowe C et al. MYC activation and BCL2L11 Silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs. Elife. 2016;5.","DOI":"10.7554\/eLife.18270"},{"issue":"6","key":"655_CR59","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1073\/pnas.0510612103","volume":"103","author":"B Zhao","year":"2006","unstructured":"Zhao B, Maruo S, Cooper A, M RC, Johannsen E, Kieff E, et al. RNAs induced by Epstein-Barr virus nuclear antigen 2 in lymphoblastoid cell lines. Proc Natl Acad Sci U S A. 2006;103(6):1900\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"655_CR60","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.chom.2014.12.013","volume":"17","author":"H Zhou","year":"2015","unstructured":"Zhou H, Schmidt SC, Jiang S, Willox B, Bernhardt K, Liang J, et al. Epstein-Barr virus oncoprotein super-enhancers control B cell growth. Cell Host Microbe. 2015;17(2):205\u201316.","journal-title":"Cell Host Microbe"},{"issue":"15","key":"655_CR61","doi-asserted-by":"publisher","first-page":"7233","DOI":"10.1093\/nar\/gks391","volume":"40","author":"K Paschos","year":"2012","unstructured":"Paschos K, Parker GA, Watanatanasup E, White RE, Allday MJ. BIM promoter directly targeted by EBNA3C in polycomb-mediated repression by EBV. Nucleic Acids Res. 2012;40(15):7233\u201346.","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"655_CR62","doi-asserted-by":"publisher","first-page":"e1006500","DOI":"10.1371\/journal.ppat.1006500","volume":"13","author":"Y Pei","year":"2017","unstructured":"Pei Y, Banerjee S, Jha HC, Sun Z, Robertson ES. An essential EBV latent antigen 3\u00a0C binds Bcl6 for targeted degradation and cell proliferation. PLoS Pathog. 2017;13(7):e1006500.","journal-title":"PLoS Pathog"},{"issue":"8","key":"655_CR63","doi-asserted-by":"publisher","first-page":"e1005844","DOI":"10.1371\/journal.ppat.1005844","volume":"12","author":"Y Pei","year":"2016","unstructured":"Pei Y, Banerjee S, Sun Z, Jha HC, Saha A, Robertson ES. EBV nuclear antigen 3\u00a0C mediates regulation of E2F6 to inhibit E2F1 transcription and promote cell proliferation. PLoS Pathog. 2016;12(8):e1005844.","journal-title":"PLoS Pathog"},{"key":"655_CR64","first-page":"61","volume":"391","author":"MJ Allday","year":"2015","unstructured":"Allday MJ, Bazot Q, White RE. The EBNA3 family: two oncoproteins and a tumour suppressor that are central to the biology of EBV in B cells. Curr Top Microbiol Immunol. 2015;391:61\u2013117.","journal-title":"Curr Top Microbiol Immunol"},{"key":"655_CR65","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fmicb.2016.00457","volume":"7","author":"S Bhattacharjee","year":"2016","unstructured":"Bhattacharjee S, Ghosh Roy S, Bose P, Saha A. Role of EBNA-3 family proteins in EBV associated B-cell lymphomagenesis. Front Microbiol. 2016;7:457.","journal-title":"Front Microbiol"},{"issue":"3","key":"655_CR66","doi-asserted-by":"publisher","first-page":"323","DOI":"10.2217\/fmb.12.147","volume":"8","author":"A Saha","year":"2013","unstructured":"Saha A, Robertson ES. Impact of EBV essential nuclear protein EBNA-3\u00a0C on B-cell proliferation and apoptosis. Future Microbiol. 2013;8(3):323\u201352.","journal-title":"Future Microbiol"},{"issue":"3","key":"655_CR67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/jmv.23208","volume":"84","author":"KR Katsumura","year":"2012","unstructured":"Katsumura KR, Maruo S, Takada K. EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes. J Med Virol. 2012;84(3):504\u201310.","journal-title":"J Med Virol"},{"issue":"49","key":"655_CR68","doi-asserted-by":"publisher","first-page":"47197","DOI":"10.1074\/jbc.M208116200","volume":"277","author":"M Hickabottom","year":"2002","unstructured":"Hickabottom M, Parker GA, Freemont P, Crook T, Allday MJ. Two nonconsensus sites in the Epstein-Barr virus oncoprotein EBNA3A cooperate to bind the co-repressor carboxyl-terminal-binding protein (CtBP). J Biol Chem. 2002;277(49):47197\u2013204.","journal-title":"J Biol Chem"},{"issue":"5","key":"655_CR69","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1073\/pnas.1019599108","volume":"108","author":"S Maruo","year":"2011","unstructured":"Maruo S, Zhao B, Johannsen E, Kieff E, Zou J, Takada K. Epstein-Barr virus nuclear antigens 3\u00a0C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression. Proc Natl Acad Sci U S A. 2011;108(5):1919\u201324.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"655_CR70","first-page":"181","volume":"391","author":"RL Skalsky","year":"2015","unstructured":"Skalsky RL, Cullen BR. EBV noncoding RNAs. Curr Top Microbiol Immunol. 2015;391:181\u2013217.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"12","key":"655_CR71","doi-asserted-by":"publisher","first-page":"9827","DOI":"10.1128\/JVI.73.12.9827-9831.1999","volume":"73","author":"J Komano","year":"1999","unstructured":"Komano J, Maruo S, Kurozumi K, Oda T, Takada K. Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt\u2019s lymphoma cell line Akata. J Virol. 1999;73(12):9827\u201331.","journal-title":"J Virol"},{"issue":"6","key":"655_CR72","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.1200\/JCO.2012.44.2301","volume":"31","author":"JK Davidson-Moncada","year":"2013","unstructured":"Davidson-Moncada JK, McDuffee E, Roschewski M. CD5+ diffuse large B-cell lymphoma with hemophagocytosis. J Clin Oncol. 2013;31(6):e76\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"655_CR73","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/s11899-012-0132-3","volume":"7","author":"K Dunleavy","year":"2012","unstructured":"Dunleavy K, Roschewski M, Wilson WH. Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes. Curr Hematol Malig Rep. 2012;7(3):208\u201315.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"655_CR74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.beha.2012.01.005","volume":"25","author":"M Roschewski","year":"2012","unstructured":"Roschewski M, Wilson WH. EBV-associated lymphomas in adults. Best Pract Res Clin Haematol. 2012;25(1):75\u201389.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"18","key":"655_CR75","doi-asserted-by":"publisher","first-page":"4207","DOI":"10.1038\/sj.emboj.7601314","volume":"25","author":"M Samanta","year":"2006","unstructured":"Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K. EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. Embo J. 2006;25(18):4207\u201314.","journal-title":"Embo J"},{"issue":"5","key":"655_CR76","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1261\/rna.2339606","volume":"12","author":"V Fok","year":"2006","unstructured":"Fok V, Mitton-Fry RM, Grech A, Steitz JA. Multiple domains of EBER 1, an Epstein-Barr virus noncoding RNA, recruit human ribosomal protein L22. RNA. 2006;12(5):872\u201382.","journal-title":"RNA"},{"issue":"6","key":"655_CR77","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3390\/v3060920","volume":"3","author":"MR Thompson","year":"2011","unstructured":"Thompson MR, Kaminski JJ, Kurt-Jones EA, Fitzgerald KA. Pattern recognition receptors and the innate immune response to viral infection. Viruses. 2011;3(6):920\u201340.","journal-title":"Viruses"},{"issue":"4","key":"655_CR78","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.cell.2015.01.015","volume":"160","author":"N Lee","year":"2015","unstructured":"Lee N, Moss WN, Yario TA, Steitz JA. EBV noncoding RNA binds nascent RNA to drive host PAX5 to viral DNA. Cell. 2015;160(4):607\u201318.","journal-title":"Cell"},{"issue":"14","key":"655_CR79","doi-asserted-by":"publisher","first-page":"6328","DOI":"10.1073\/pnas.0914843107","volume":"107","author":"DM Pegtel","year":"2010","unstructured":"Pegtel DM, Cosmopoulos K, Thorley-Lawson DA, van Eijndhoven MA, Hopmans ES, Lindenberg JL, et al. Functional delivery of viral MiRNAs via exosomes. Proc Natl Acad Sci U S A. 2010;107(14):6328\u201333.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"655_CR80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.semcancer.2014.02.002","volume":"26","author":"O Klinke","year":"2014","unstructured":"Klinke O, Feederle R, Delecluse HJ. Genetics of Epstein-Barr virus MicroRNAs. Semin Cancer Biol. 2014;26:52\u20139.","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"655_CR81","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1093\/nar\/gkq1043","volume":"39","author":"J Imig","year":"2011","unstructured":"Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T, et al. MicroRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 2011;39(5):1880\u201393.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"655_CR82","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.virol.2009.01.006","volume":"386","author":"ZL Pratt","year":"2009","unstructured":"Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B. The MicroRNAs of Epstein-Barr virus are expressed at dramatically differing levels among cell lines. Virology. 2009;386(2):387\u201397.","journal-title":"Virology"},{"issue":"19","key":"655_CR83","doi-asserted-by":"publisher","first-page":"9801","DOI":"10.1128\/JVI.05100-11","volume":"85","author":"R Feederle","year":"2011","unstructured":"Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, Lips H, et al. The members of an Epstein-Barr virus MicroRNA cluster cooperate to transform B lymphocytes. J Virol. 2011;85(19):9801\u201310.","journal-title":"J Virol"},{"issue":"21","key":"655_CR84","doi-asserted-by":"publisher","first-page":"E1396","DOI":"10.1073\/pnas.1115906109","volume":"109","author":"S Jochum","year":"2012","unstructured":"Jochum S, Ruiss R, Moosmann A, Hammerschmidt W, Zeidler R. RNAs in Epstein-Barr virions control early steps of infection. Proc Natl Acad Sci U S A. 2012;109(21):E1396\u2013404.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"655_CR85","doi-asserted-by":"publisher","first-page":"e1005405","DOI":"10.1371\/journal.ppat.1005405","volume":"12","author":"K Bernhardt","year":"2016","unstructured":"Bernhardt K, Haar J, Tsai MH, Poirey R, Feederle R, Delecluse HJ. A viral MicroRNA cluster regulates the expression of PTEN, p27 and of a bcl-2 homolog. PLoS Pathog. 2016;12(1):e1005405.","journal-title":"PLoS Pathog"},{"issue":"17","key":"655_CR86","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1038\/onc.2014.341","volume":"34","author":"LM Cai","year":"2015","unstructured":"Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, Yuan CC, et al. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene. 2015;34(17):2156\u201366.","journal-title":"Oncogene"},{"issue":"6","key":"655_CR87","doi-asserted-by":"publisher","first-page":"e1004979","DOI":"10.1371\/journal.ppat.1004979","volume":"11","author":"D Kang","year":"2015","unstructured":"Kang D, Skalsky RL, Cullen BR. EBV BART MicroRNAs target multiple Pro-apoptotic cellular genes to promote epithelial cell survival. PLoS Pathog. 2015;11(6):e1004979.","journal-title":"PLoS Pathog"},{"key":"655_CR88","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.coviro.2014.04.003","volume":"7","author":"M Kuzembayeva","year":"2014","unstructured":"Kuzembayeva M, Hayes M, Sugden B. Multiple functions are mediated by the MiRNAs of Epstein-Barr virus. Curr Opin Virol. 2014;7:61\u20135.","journal-title":"Curr Opin Virol"},{"issue":"3","key":"655_CR89","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/ajt.14603","volume":"18","author":"VR Dharnidharka","year":"2018","unstructured":"Dharnidharka VR. Comprehensive review of post-organ transplant hematologic cancers. Am J Transpl. 2018;18(3):537\u201349.","journal-title":"Am J Transpl"},{"issue":"3","key":"655_CR90","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11899-013-0162-5","volume":"8","author":"Z Al-Mansour","year":"2013","unstructured":"Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8(3):173\u201383.","journal-title":"Curr Hematol Malig Rep"},{"issue":"3","key":"655_CR91","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/ajt.14020","volume":"17","author":"MA AlDabbagh","year":"2017","unstructured":"AlDabbagh MA, Gitman MR, Kumar D, Humar A, Rotstein C, Husain S. The role of antiviral prophylaxis for the prevention of Epstein-Barr Virus-Associated posttransplant lymphoproliferative disease in solid organ transplant recipients: A systematic review. Am J Transpl. 2017;17(3):770\u201381.","journal-title":"Am J Transpl"},{"issue":"7","key":"655_CR92","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1182\/blood.2020005470","volume":"139","author":"E Cesarman","year":"2022","unstructured":"Cesarman E, Chadburn A, Rubinstein PG. KSHV\/HHV8-mediated hematologic diseases. Blood. 2022;139(7):1013\u201325.","journal-title":"Blood"},{"key":"655_CR93","doi-asserted-by":"crossref","unstructured":"n der Meulen E, Anderton M, Blumenthal MJ, Sch\u00e4fer G. Cellular receptors involved in KSHV infection. Viruses. 2021;13(1).","DOI":"10.3390\/v13010118"},{"issue":"1","key":"655_CR94","doi-asserted-by":"publisher","first-page":"e1009179","DOI":"10.1371\/journal.ppat.1009179","volume":"17","author":"YJ Kim","year":"2021","unstructured":"Kim YJ, Kim Y, Kumar A, Kim CW, Toth Z, Cho NH, et al. Kaposi\u2019s sarcoma-associated herpesvirus latency-associated nuclear antigen dysregulates expression of MCL-1 by targeting FBW7. PLoS Pathog. 2021;17(1):e1009179.","journal-title":"PLoS Pathog"},{"key":"655_CR95","doi-asserted-by":"crossref","unstructured":"Juillard F, De Le\u00f3n V\u00e1zquez E, Tan M, Li S, Kaye KM. Kaposi\u2019s Sarcoma-Associated Herpesvirus LANA-Adjacent Regions with Distinct Functions in Episome Segregation or Maintenance. J Virol. 2019;93(6).","DOI":"10.1128\/JVI.02158-18"},{"issue":"22","key":"655_CR96","doi-asserted-by":"publisher","first-page":"12895","DOI":"10.1093\/nar\/gkab1094","volume":"49","author":"M Tan","year":"2021","unstructured":"Tan M, Li S, Juillard F, Chitas R, Cust\u00f3dio TF, Xue H, et al. MLL1 is regulated by KSHV LANA and is important for virus latency. Nucleic Acids Res. 2021;49(22):12895\u2013911.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"655_CR97","doi-asserted-by":"publisher","first-page":"e1005648","DOI":"10.1371\/journal.ppat.1005648","volume":"12","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Ramos da Silva S, He M, Liang Q, Lu C, Feng P, et al. An oncogenic virus promotes cell survival and cellular transformation by suppressing Glycolysis. PLoS Pathog. 2016;12(5):e1005648.","journal-title":"PLoS Pathog"},{"issue":"5","key":"655_CR98","doi-asserted-by":"publisher","first-page":"e1007062","DOI":"10.1371\/journal.ppat.1007062","volume":"14","author":"RK Singh","year":"2018","unstructured":"Singh RK, Lang F, Pei Y, Jha HC, Robertson ES. Metabolic reprogramming of Kaposi\u2019s sarcoma associated herpes virus infected B-cells in hypoxia. PLoS Pathog. 2018;14(5):e1007062.","journal-title":"PLoS Pathog"},{"issue":"9","key":"655_CR99","doi-asserted-by":"publisher","first-page":"e1004400","DOI":"10.1371\/journal.ppat.1004400","volume":"10","author":"O Yogev","year":"2014","unstructured":"Yogev O, Lagos D, Enver T, Boshoff C. Kaposi\u2019s sarcoma herpesvirus MicroRNAs induce metabolic transformation of infected cells. PLoS Pathog. 2014;10(9):e1004400.","journal-title":"PLoS Pathog"},{"issue":"8","key":"655_CR100","doi-asserted-by":"publisher","first-page":"e1011581","DOI":"10.1371\/journal.ppat.1011581","volume":"19","author":"J Lan","year":"2023","unstructured":"Lan J, Wang Y, Yue S, Xu D, Li Y, Peng X, et al. Targeting FoxO proteins induces lytic reactivation of KSHV for treating herpesviral primary effusion lymphoma. PLoS Pathog. 2023;19(8):e1011581.","journal-title":"PLoS Pathog"},{"issue":"10","key":"655_CR101","doi-asserted-by":"publisher","first-page":"e1004389","DOI":"10.1371\/journal.ppat.1004389","volume":"10","author":"M Valiya Veettil","year":"2014","unstructured":"Valiya Veettil M, Dutta D, Bottero V, Bandyopadhyay C, Gjyshi O, Sharma-Walia N, et al. Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi\u2019s sarcoma-associated herpesvirus infection promotes cell proliferation. PLoS Pathog. 2014;10(10):e1004389.","journal-title":"PLoS Pathog"},{"issue":"2","key":"655_CR102","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.neuropharm.2003.08.006","volume":"46","author":"SA Patel","year":"2004","unstructured":"Patel SA, Warren BA, Rhoderick JF, Bridges RJ. Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine. Neuropharmacology. 2004;46(2):273\u201384.","journal-title":"Neuropharmacology"},{"key":"655_CR103","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1756-8722-7-30","volume":"7","author":"L Dai","year":"2014","unstructured":"Dai L, Cao Y, Chen Y, Parsons C, Qin Z. Targeting xCT, a cystine-glutamate transporter induces apoptosis and tumor regression for KSHV\/HIV-associated lymphoma. J Hematol Oncol. 2014;7:30.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"655_CR104","doi-asserted-by":"publisher","first-page":"e0138623","DOI":"10.1128\/jvi.01386-23","volume":"98","author":"Y Izumiya","year":"2024","unstructured":"Izumiya Y, Algalil A, Espera JM, Miura H, Izumiya C, Inagaki T, et al. Kaposi\u2019s sarcoma-associated herpesvirus terminal repeat regulates inducible lytic gene promoters. J Virol. 2024;98(2):e0138623.","journal-title":"J Virol"},{"issue":"3","key":"655_CR105","doi-asserted-by":"publisher","first-page":"113888","DOI":"10.1016\/j.celrep.2024.113888","volume":"43","author":"X Ye","year":"2024","unstructured":"Ye X, Guerin LN, Chen Z, Rajendren S, Dunker W, Zhao Y, et al. Enhancer-promoter activation by the Kaposi sarcoma-associated herpesvirus episome maintenance protein LANA. Cell Rep. 2024;43(3):113888.","journal-title":"Cell Rep"},{"issue":"1","key":"655_CR106","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.chom.2017.06.009","volume":"22","author":"D McHugh","year":"2017","unstructured":"McHugh D, Caduff N, Barros MHM, R\u00e4mer PC, Raykova A, Murer A, et al. Persistent KSHV infection increases EBV-Associated tumor formation in vivo via enhanced EBV lytic gene expression. Cell Host Microbe. 2017;22(1):61\u2013e737.","journal-title":"Cell Host Microbe"},{"issue":"20","key":"655_CR107","doi-asserted-by":"publisher","first-page":"10416","DOI":"10.1128\/JVI.01525-15","volume":"89","author":"C Wang","year":"2015","unstructured":"Wang C, Zhu C, Wei F, Zhang L, Mo X, Feng Y, et al. Constitutive activation of Interleukin-13\/STAT6 contributes to Kaposi\u2019s Sarcoma-Associated Herpesvirus-Related primary effusion lymphoma cell proliferation and survival. J Virol. 2015;89(20):10416\u201326.","journal-title":"J Virol"},{"issue":"20","key":"655_CR108","doi-asserted-by":"publisher","first-page":"12167","DOI":"10.1128\/JVI.01751-14","volume":"88","author":"E Cousins","year":"2014","unstructured":"Cousins E, Gao Y, Sandford G, Nicholas J. Human herpesvirus 8 viral interleukin-6 signaling through gp130 promotes virus replication in primary effusion lymphoma and endothelial cells. J Virol. 2014;88(20):12167\u201372.","journal-title":"J Virol"},{"key":"655_CR109","first-page":"1052","volume":"7","author":"X Li","year":"2016","unstructured":"Li X, Bhaduri-McIntosh S. A central role for STAT3 in Gammaherpesvirus-Life cycle and -Diseases. Front Microbiol. 2016;7:1052.","journal-title":"Front Microbiol"},{"key":"655_CR110","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.3389\/fmicb.2019.01544","volume":"10","author":"R Rivera-Soto","year":"2019","unstructured":"Rivera-Soto R, Damania B. Modulation of angiogenic processes by the human gammaherpesviruses, Epstein-Barr virus and Kaposi\u2019s Sarcoma-Associated herpesvirus. Front Microbiol. 2019;10:1544.","journal-title":"Front Microbiol"},{"key":"655_CR111","doi-asserted-by":"crossref","unstructured":"Rivera-Soto R, Dissinger NJ, Damania B. Kaposi\u2019s Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin \u03b23 Levels and Is Dependent on STAT3. J Virol. 2020;94(5).","DOI":"10.1128\/JVI.01384-19"},{"issue":"4","key":"655_CR112","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","volume":"50","author":"S Kang","year":"2019","unstructured":"Kang S, Tanaka T, Narazaki M, Kishimoto T. Targeting Interleukin-6 signaling in clinic. Immunity. 2019;50(4):1007\u201323.","journal-title":"Immunity"},{"issue":"2","key":"655_CR113","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1128\/JVI.02830-13","volume":"88","author":"D Chen","year":"2014","unstructured":"Chen D, Gao Y, Nicholas J. Human herpesvirus 8 interleukin-6 contributes to primary effusion lymphoma cell viability via suppression of proapoptotic cathepsin D, a Cointeraction partner of vitamin K epoxide reductase complex subunit 1 variant 2. J Virol. 2014;88(2):1025\u201338.","journal-title":"J Virol"},{"issue":"5","key":"655_CR114","doi-asserted-by":"publisher","first-page":"e0125525","DOI":"10.1371\/journal.pone.0125525","volume":"10","author":"TH Dinh","year":"2015","unstructured":"Dinh TH, Delaney KP, Goga A, Jackson D, Lombard C, Woldesenbet S, et al. Impact of maternal HIV seroconversion during pregnancy on early mother to child transmission of HIV (MTCT) measured at 4-8 weeks postpartum in South Africa 2011-2012: A National Population-Based evaluation. PLoS ONE. 2015;10(5):e0125525.","journal-title":"PLoS ONE"},{"key":"655_CR115","doi-asserted-by":"crossref","unstructured":"Tagaya Y, Matsuoka M, Gallo R. 40 Years of the human T-cell leukemia virus: past, present, and future. F1000Res. 2019;8.","DOI":"10.12688\/f1000research.17479.1"},{"key":"655_CR116","doi-asserted-by":"crossref","unstructured":"Kalinichenko S, Komkov D, Mazurov D. HIV-1 and HTLV-1 transmission modes: mechanisms and importance for virus spread. Viruses. 2022;14(1).","DOI":"10.3390\/v14010152"},{"key":"655_CR117","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-immunol-042617-053222","volume":"36","author":"CRM Bangham","year":"2018","unstructured":"Bangham CRM, Human T. Cell leukemia virus type 1: persistence and pathogenesis. Annu Rev Immunol. 2018;36:43\u201371.","journal-title":"Annu Rev Immunol"},{"issue":"5","key":"655_CR118","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11(5):325\u201337.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"655_CR119","doi-asserted-by":"publisher","first-page":"e2204808","DOI":"10.1002\/advs.202204808","volume":"10","author":"J Zhao","year":"2023","unstructured":"Zhao J, Tian Z, Zhao S, Feng D, Guo Z, Wen L, et al. Insights into the effect of catalytic intratumoral lactate depletion on metabolic reprogramming and immune activation for antitumoral activity. Adv Sci (Weinh). 2023;10(4):e2204808.","journal-title":"Adv Sci (Weinh)"},{"issue":"11","key":"655_CR120","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.chembiol.2017.08.016","volume":"24","author":"A Kulkarni","year":"2017","unstructured":"Kulkarni A, Mateus M, Thinnes CC, McCullagh JS, Schofield CJ, Taylor GP, et al. Glucose metabolism and oxygen availability govern reactivation of the latent human retrovirus HTLV-1. Cell Chem Biol. 2017;24(11):1377\u2013e873.","journal-title":"Cell Chem Biol"},{"key":"655_CR121","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virol.2018.05.007","volume":"520","author":"T Hutchison","year":"2018","unstructured":"Hutchison T, Malu A, Yapindi L, Bergeson R, Peck K, Romeo M, et al. The TP53-Induced Glycolysis and apoptosis regulator mediates Cooperation between HTLV-1 p30(II) and the retroviral oncoproteins tax and HBZ and is highly expressed in an in vivo xenograft model of HTLV-1-induced lymphoma. Virology. 2018;520:39\u201358.","journal-title":"Virology"},{"issue":"5","key":"655_CR122","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1158\/2643-3230.BCD-22-0139","volume":"4","author":"K Toyoda","year":"2023","unstructured":"Toyoda K, Yasunaga JI, Shichijo T, Arima Y, Tsujita K, Tanaka A, et al. HTLV-1 bZIP Factor-Induced reprogramming of lactate metabolism and epigenetic status promote leukemic cell expansion. Blood Cancer Discov. 2023;4(5):374\u201393.","journal-title":"Blood Cancer Discov"},{"issue":"1","key":"655_CR123","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s11033-019-05171-1","volume":"47","author":"R Derakhshan","year":"2020","unstructured":"Derakhshan R, Mirhosseini A, Ahmadi Ghezeldasht S, Jahantigh HR, Mohareri M, Boostani R, et al. Abnormal vitamin D and lipid profile in HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) patients. Mol Biol Rep. 2020;47(1):631\u20137.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"655_CR124","doi-asserted-by":"publisher","first-page":"A115","DOI":"10.1186\/1742-4690-8-S1-A115","volume":"8","author":"ES Rodrigues","year":"2011","unstructured":"Rodrigues ES, Rocha MC, Orellana MD, Takayanagui OM, Covas DT, Kashima S. HTLV-1 affects the adipogenic differentiation of human mesenchymal stem cells. Retrovirology. 2011;8(1):A115.","journal-title":"Retrovirology"},{"issue":"4","key":"655_CR125","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.molcel.2008.11.004","volume":"32","author":"R Margueron","year":"2008","unstructured":"Margueron R, Li G, Sarma K, Blais A, Zavadil J, Woodcock CL, et al. Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms. Mol Cell. 2008;32(4):503\u201318.","journal-title":"Mol Cell"},{"issue":"4","key":"655_CR126","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2008.10.016","volume":"32","author":"X Shen","year":"2008","unstructured":"Shen X, Liu Y, Hsu YJ, Fujiwara Y, Kim J, Mao X, et al. EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. Mol Cell. 2008;32(4):491\u2013502.","journal-title":"Mol Cell"},{"issue":"8","key":"655_CR127","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1016\/j.celrep.2019.10.083","volume":"29","author":"M Yamagishi","year":"2019","unstructured":"Yamagishi M, Hori M, Fujikawa D, Ohsugi T, Honma D, Adachi N, et al. Targeting excessive EZH1 and EZH2 activities for abnormal histone methylation and transcription network in malignant lymphomas. Cell Rep. 2019;29(8):2321\u2013e377.","journal-title":"Cell Rep"},{"issue":"11","key":"655_CR128","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S1470-2045(20)30441-1","volume":"21","author":"F Morschhauser","year":"2020","unstructured":"Morschhauser F, Tilly H, Chaidos A, McKay P, Phillips T, Assouline S, et al. Tazemetostat for patients with relapsed or refractory follicular lymphoma: an open-label, single-arm, multicentre, phase 2 trial. Lancet Oncol. 2020;21(11):1433\u201342.","journal-title":"Lancet Oncol"},{"issue":"11","key":"655_CR129","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/S1470-2045(20)30451-4","volume":"21","author":"M Gounder","year":"2020","unstructured":"Gounder M, Sch\u00f6ffski P, Jones RL, Agulnik M, Cote GM, Villalobos VM, et al. Tazemetostat in advanced epithelioid sarcoma with loss of INI1\/SMARCB1: an international, open-label, phase 2 basket study. Lancet Oncol. 2020;21(11):1423\u201332.","journal-title":"Lancet Oncol"},{"issue":"11","key":"655_CR130","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ng.3415","volume":"47","author":"K Kataoka","year":"2015","unstructured":"Kataoka K, Nagata Y, Kitanaka A, Shiraishi Y, Shimamura T, Yasunaga J, et al. Integrated molecular analysis of adult T cell leukemia\/lymphoma. Nat Genet. 2015;47(11):1304\u201315.","journal-title":"Nat Genet"},{"issue":"10","key":"655_CR131","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1182\/blood.V97.10.3177","volume":"97","author":"J Yasunaga","year":"2001","unstructured":"Yasunaga J, Sakai T, Nosaka K, Etoh K, Tamiya S, Koga S, et al. Impaired production of Naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood. 2001;97(10):3177\u201383.","journal-title":"Blood"},{"key":"655_CR132","doi-asserted-by":"crossref","unstructured":"Umekita K, Hashikura Y, Takaki A, Kimura M, Kawano K, Iwao C et al. HAS-Flow May be an adequate method for evaluating human T-Cell leukemia virus type 1 infected cells in human T-Cell leukemia virus type 1-Positive rheumatoid arthritis patients receiving antirheumatic therapies: A retrospective Cross-Sectional observation study. Viruses. 2023;15(2).","DOI":"10.3390\/v15020468"},{"key":"655_CR133","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1742-4690-9-46","volume":"9","author":"Y Satou","year":"2012","unstructured":"Satou Y, Utsunomiya A, Tanabe J, Nakagawa M, Nosaka K, Matsuoka M. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals. Retrovirology. 2012;9:46.","journal-title":"Retrovirology"},{"issue":"17","key":"655_CR134","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1182\/blood.2019002038","volume":"134","author":"DA Rauch","year":"2019","unstructured":"Rauch DA, Conlon KC, Janakiram M, Brammer JE, Harding JC, Ye BH, et al. Rapid progression of adult T-cell leukemia\/lymphoma as tumor-infiltrating Tregs after PD-1 Blockade. Blood. 2019;134(17):1406\u201314.","journal-title":"Blood"},{"key":"655_CR135","doi-asserted-by":"publisher","first-page":"991928","DOI":"10.3389\/fimmu.2022.991928","volume":"13","author":"BJY Tan","year":"2022","unstructured":"Tan BJY, Sugata K, Ono M, Satou Y. HTLV-1 persistence and leukemogenesis: A game of hide-and-seek with the host immune system. Front Immunol. 2022;13:991928.","journal-title":"Front Immunol"},{"issue":"1","key":"655_CR136","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4049\/jimmunol.0903846","volume":"185","author":"F Toulza","year":"2010","unstructured":"Toulza F, Nosaka K, Tanaka Y, Schioppa T, Balkwill F, Taylor GP, et al. Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells. J Immunol. 2010;185(1):183\u20139.","journal-title":"J Immunol"},{"issue":"10","key":"655_CR137","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1182\/blood-2007-10-118539","volume":"111","author":"F Toulza","year":"2008","unstructured":"Toulza F, Heaps A, Tanaka Y, Taylor GP, Bangham CR. High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response. Blood. 2008;111(10):5047\u201353.","journal-title":"Blood"},{"issue":"5","key":"655_CR138","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/modpathol.2008.25","volume":"21","author":"K Karube","year":"2008","unstructured":"Karube K, Aoki R, Sugita Y, Yoshida S, Nomura Y, Shimizu K, et al. The relationship of FOXP3 expression and clinicopathological characteristics in adult T-cell leukemia\/lymphoma. Mod Pathol. 2008;21(5):617\u201325.","journal-title":"Mod Pathol"},{"key":"655_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-9-1","volume":"9","author":"J Juno","year":"2012","unstructured":"Juno J, Tuff J, Choi R, Card C, Kimani J, Wachihi C, et al. The role of G protein gene GNB3 C825T polymorphism in HIV-1 acquisition, progression and immune activation. Retrovirology. 2012;9:1.","journal-title":"Retrovirology"},{"issue":"1","key":"655_CR140","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","volume":"99","author":"T Shimauchi","year":"2008","unstructured":"Shimauchi T, Kabashima K, Tokura Y. Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells. Cancer Sci. 2008;99(1):98\u2013106.","journal-title":"Cancer Sci"},{"issue":"7","key":"655_CR141","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1182\/blood-2010-12-326199","volume":"118","author":"T Zhao","year":"2011","unstructured":"Zhao T, Satou Y, Sugata K, Miyazato P, Green PL, Imamura T, et al. HTLV-1 bZIP factor enhances TGF-\u03b2 signaling through p300 coactivator. Blood. 2011;118(7):1865\u201376.","journal-title":"Blood"},{"issue":"2","key":"655_CR142","doi-asserted-by":"publisher","first-page":"e1001274","DOI":"10.1371\/journal.ppat.1001274","volume":"7","author":"Y Satou","year":"2011","unstructured":"Satou Y, Yasunaga J, Zhao T, Yoshida M, Miyazato P, Takai K, et al. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011;7(2):e1001274.","journal-title":"PLoS Pathog"},{"issue":"12","key":"655_CR143","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1002\/ijc.21688","volume":"118","author":"A Inagaki","year":"2006","unstructured":"Inagaki A, Ishida T, Ishii T, Komatsu H, Iida S, Ding J, et al. Clinical significance of serum Th1-, Th2- and regulatory T cells-associated cytokines in adult T-cell leukemia\/lymphoma: high interleukin-5 and -10 levels are significant unfavorable prognostic factors. Int J Cancer. 2006;118(12):3054\u201361.","journal-title":"Int J Cancer"},{"issue":"2","key":"655_CR144","doi-asserted-by":"publisher","first-page":"e1006861","DOI":"10.1371\/journal.ppat.1006861","volume":"14","author":"H Kagdi","year":"2018","unstructured":"Kagdi H, Demontis MA, Ramos JC, Taylor GP. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection. PLoS Pathog. 2018;14(2):e1006861.","journal-title":"PLoS Pathog"},{"issue":"1","key":"655_CR145","doi-asserted-by":"publisher","first-page":"e1005372","DOI":"10.1371\/journal.ppat.1005372","volume":"12","author":"K Yasuma","year":"2016","unstructured":"Yasuma K, Yasunaga J, Takemoto K, Sugata K, Mitobe Y, Takenouchi N, et al. HTLV-1 bZIP factor impairs Anti-viral immunity by inducing Co-inhibitory molecule, T cell Immunoglobulin and ITIM domain (TIGIT). PLoS Pathog. 2016;12(1):e1005372.","journal-title":"PLoS Pathog"},{"key":"655_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2013.00001","volume":"4","author":"OZ Cheng","year":"2013","unstructured":"Cheng OZ, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front Immunol. 2013;4:1.","journal-title":"Front Immunol"},{"issue":"9","key":"655_CR147","doi-asserted-by":"publisher","first-page":"e1006597","DOI":"10.1371\/journal.ppat.1006597","volume":"13","author":"L Sawada","year":"2017","unstructured":"Sawada L, Nagano Y, Hasegawa A, Kanai H, Nogami K, Ito S, et al. IL-10-mediated signals act as a switch for lymphoproliferation in human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways. PLoS Pathog. 2017;13(9):e1006597.","journal-title":"PLoS Pathog"},{"issue":"24","key":"655_CR148","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1073\/pnas.1922884117","volume":"117","author":"Y Higuchi","year":"2020","unstructured":"Higuchi Y, Yasunaga JI, Mitagami Y, Tsukamoto H, Nakashima K, Ohshima K, et al. HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling. Proc Natl Acad Sci U S A. 2020;117(24):13740\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"655_CR149","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1002\/jmv.25653","volume":"92","author":"M Kim","year":"2020","unstructured":"Kim M, Lee YK, Park B, Oh DJ, Choi HG. Hepatitis virus B and C infections are associated with an increased risk of non-Hodgkin lymphoma: A nested case-control study using a National sample cohort. J Med Virol. 2020;92(8):1214\u201320.","journal-title":"J Med Virol"},{"issue":"5","key":"655_CR150","doi-asserted-by":"publisher","first-page":"e0217161","DOI":"10.1371\/journal.pone.0217161","volume":"14","author":"X Qi","year":"2019","unstructured":"Qi X, Gui X, Zhuang K. Establishment and characterization of HBV-associated B lymphocytes with an immortalization potential. PLoS ONE. 2019;14(5):e0217161.","journal-title":"PLoS ONE"},{"issue":"7","key":"655_CR151","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1128\/jvi.66.7.4382-4389.1992","volume":"66","author":"L Kwee","year":"1992","unstructured":"Kwee L, Lucito R, Aufiero B, Schneider RJ. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol. 1992;66(7):4382\u20139.","journal-title":"J Virol"},{"key":"655_CR152","doi-asserted-by":"publisher","first-page":"104925","DOI":"10.1016\/j.antiviral.2020.104925","volume":"182","author":"S Tsukuda","year":"2020","unstructured":"Tsukuda S, Watashi K. Hepatitis B virus biology and life cycle. Antiviral Res. 2020;182:104925.","journal-title":"Antiviral Res"},{"issue":"2","key":"655_CR153","first-page":"253","volume":"117","author":"P Cacoub","year":"2022","unstructured":"Cacoub P, Asselah T, Hepatitis B. Virus infection and Extra-Hepatic manifestations: A systemic disease. Am J Gastroenterol. 2022;117(2):253\u201363.","journal-title":"Am J Gastroenterol"},{"key":"655_CR154","doi-asserted-by":"crossref","unstructured":"Herrscher C, Roingeard P, Blanchard E. Hepatitis B virus entry into cells. Cells. 2020;9(6).","DOI":"10.3390\/cells9061486"},{"issue":"9","key":"655_CR155","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3748\/wjg.v28.i9.881","volume":"28","author":"HJ Zhao","year":"2022","unstructured":"Zhao HJ, Hu YF, Han QJ, Zhang J. Innate and adaptive immune escape mechanisms of hepatitis B virus. World J Gastroenterol. 2022;28(9):881\u201396.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"655_CR156","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LA O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553\u201365.","journal-title":"Nat Rev Immunol"},{"issue":"12","key":"655_CR157","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1002\/jmv.25851","volume":"92","author":"Q Hao","year":"2020","unstructured":"Hao Q, Wang Z, Wang Q, Xia W, Cao H, Lu Z, et al. Differential expression profile of long noncoding RNAs in chronic HBV infection: new insights into pathogenesis. J Med Virol. 2020;92(12):3390\u2013402.","journal-title":"J Med Virol"},{"key":"655_CR158","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13073-015-0230-7","volume":"7","author":"A Verma","year":"2015","unstructured":"Verma A, Jiang Y, Du W, Fairchild L, Melnick A, Elemento O. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma. Genome Med. 2015;7:110.","journal-title":"Genome Med"},{"issue":"22","key":"655_CR159","doi-asserted-by":"publisher","first-page":"10350","DOI":"10.1073\/pnas.91.22.10350","volume":"91","author":"J Benn","year":"1994","unstructured":"Benn J, Schneider RJ. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci U S A. 1994;91(22):10350\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"655_CR160","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1073\/pnas.92.24.11215","volume":"92","author":"J Benn","year":"1995","unstructured":"Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci U S A. 1995;92(24):11215\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"655_CR161","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.omtn.2022.01.015","volume":"27","author":"J Li","year":"2022","unstructured":"Li J, Chen Y, Guo X, Bai X, Xu X, Han T, et al. lncNBAT1\/APOBEC3A is a mediator of HBX-induced chemoresistance in diffuse large B cell lymphoma cells. Mol Ther Nucleic Acids. 2022;27:1064\u201377.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"Suppl 5","key":"655_CR162","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1186\/1471-2334-14-S5-S6","volume":"14","author":"R Bruni","year":"2014","unstructured":"Bruni R, Marcantonio C, Pulsoni A, Tataseo P, De Angelis F, Spada E, et al. MicroRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virus. BMC Infect Dis. 2014;14(Suppl 5):S6.","journal-title":"BMC Infect Dis"},{"key":"655_CR163","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.2147\/CMAR.S202664","volume":"11","author":"R Han","year":"2019","unstructured":"Han R, Chen X, Li Y, Zhang S, Li R, Lu L. MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3. Cancer Manag Res. 2019;11:2963\u201376.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"655_CR164","first-page":"479","volume":"11","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Ren H, Li J, Xue R, Liu H, Zhu Z, et al. Elevated HMGB1 expression induced by hepatitis B virus X protein promotes epithelial-mesenchymal transition and angiogenesis through STAT3\/miR-34a\/NF-\u03baB in primary liver cancer. Am J Cancer Res. 2021;11(2):479\u201394.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"655_CR165","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/kjm2.12283","volume":"36","author":"J Peng","year":"2020","unstructured":"Peng J, Li SJ, Fu X, Liu Y, Zhao XL. Chidamide acts on the histone deacetylase-mediated miR-34a\/Bcl-2 axis to regulate NB4 cell line proliferation and apoptosis. Kaohsiung J Med Sci. 2020;36(12):1004\u201313.","journal-title":"Kaohsiung J Med Sci"},{"issue":"36","key":"655_CR166","doi-asserted-by":"publisher","first-page":"9701","DOI":"10.1073\/pnas.1619555114","volume":"114","author":"H Hashwah","year":"2017","unstructured":"Hashwah H, Schmid CA, Kasser S, Bertram K, Stelling A, Manz MG, et al. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth. Proc Natl Acad Sci U S A. 2017;114(36):9701\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"655_CR167","doi-asserted-by":"publisher","first-page":"3624635","DOI":"10.1155\/2023\/3624635","volume":"2023","author":"Y Li","year":"2023","unstructured":"Li Y, Wang Y, Song Z, Lu K, Chen W, Ma Y, et al. Protein acetylation increased risk of Fibrosis-Related liver Cancer. J Oncol. 2023;2023:3624635.","journal-title":"J Oncol"},{"issue":"3","key":"655_CR168","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.immuni.2019.08.006","volume":"51","author":"SN Meyer","year":"2019","unstructured":"Meyer SN, Scuoppo C, Vlasevska S, Bal E, Holmes AB, Holloman M, et al. Unique and shared epigenetic programs of the CREBBP and EP300 acetyltransferases in germinal center B cells reveal targetable dependencies in lymphoma. Immunity. 2019;51(3):535\u2013e479.","journal-title":"Immunity"},{"issue":"4","key":"655_CR169","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/ng1018","volume":"32","author":"OR Bereshchenko","year":"2002","unstructured":"Bereshchenko OR, Gu W, Dalla-Favera R. Acetylation inactivates the transcriptional repressor BCL6. Nat Genet. 2002;32(4):606\u201313.","journal-title":"Nat Genet"},{"key":"655_CR170","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.leukres.2017.02.012","volume":"57","author":"R Frazzi","year":"2017","unstructured":"Frazzi R, Zanetti E, Pistoni M, Tamagnini I, Valli R, Braglia L, et al. Methylation changes of SIRT1, KLF4, DAPK1 and SPG20 in B-lymphocytes derived from follicular and diffuse large B-cell lymphoma. Leuk Res. 2017;57:89\u201396.","journal-title":"Leuk Res"},{"issue":"1","key":"655_CR171","doi-asserted-by":"publisher","first-page":"433","DOI":"10.3892\/ol.2017.6114","volume":"14","author":"J Bo","year":"2017","unstructured":"Bo J, Wang X, Li J, Wang W, Zhang J. Consecutive stimulation of HBsAg promotes the viability of the human B lymphoblastoid cell line IM-9 through regulating the SIRT1-NF-\u03baB pathway. Oncol Lett. 2017;14(1):433\u201340.","journal-title":"Oncol Lett"},{"issue":"1","key":"655_CR172","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jhep.2023.02.035","volume":"79","author":"I Montali","year":"2023","unstructured":"Montali I, Ceccatelli Berti C, Morselli M, Acerbi G, Barili V, Pedrazzi G, et al. Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B. J Hepatol. 2023;79(1):50\u201360.","journal-title":"J Hepatol"},{"issue":"10","key":"655_CR173","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1172\/JCI121960","volume":"128","author":"AR Burton","year":"2018","unstructured":"Burton AR, Pallett LJ, McCoy LE, Suveizdyte K, Amin OE, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Investig. 2018;128(10):4588\u2013603.","journal-title":"J Clin Investig"},{"issue":"10","key":"655_CR174","doi-asserted-by":"publisher","first-page":"4573","DOI":"10.1172\/JCI121957","volume":"128","author":"L Salimzadeh","year":"2018","unstructured":"Salimzadeh L, Le Bert N, Dutertre CA, Gill US, Newell EW, Frey C, et al. PD-1 Blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection. J Clin Investig. 2018;128(10):4573\u201387.","journal-title":"J Clin Investig"},{"issue":"3","key":"655_CR175","doi-asserted-by":"publisher","first-page":"110713","DOI":"10.1016\/j.celrep.2022.110713","volume":"39","author":"X Ye","year":"2022","unstructured":"Ye X, Wang L, Nie M, Wang Y, Dong S, Ren W, et al. A single-cell atlas of diffuse large B cell lymphoma. Cell Rep. 2022;39(3):110713.","journal-title":"Cell Rep"},{"issue":"5","key":"655_CR176","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med. 2018;24(5):679\u201390.","journal-title":"Nat Med"},{"issue":"1","key":"655_CR177","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jhep.2013.08.016","volume":"60","author":"P Foka","year":"2014","unstructured":"Foka P, Karamichali E, Dalagiorgou G, Serti E, Doumba PP, Pissas G, et al. Hepatitis C virus modulates lipid regulatory factor Angiopoietin-like 3 gene expression by repressing HNF-1\u03b1 activity. J Hepatol. 2014;60(1):30\u20138.","journal-title":"J Hepatol"},{"issue":"3","key":"655_CR178","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s12038-017-9695-4","volume":"42","author":"V Sedeno-Monge","year":"2017","unstructured":"Sedeno-Monge V, Vallejo-Ruiz V, Sosa-Jurado F, Santos-Lopez G. Polymorphisms in the hepatitis C virus core and its association with development of hepatocellular carcinoma. J Biosci. 2017;42(3):509\u201321.","journal-title":"J Biosci"},{"issue":"6","key":"655_CR179","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ajpath.2019.01.018","volume":"189","author":"MC Navas","year":"2019","unstructured":"Navas MC, Glaser S, Dhruv H, Celinski S, Alpini G, Meng F. Hepatitis C virus infection and cholangiocarcinoma: an insight into epidemiologic evidences and hypothetical mechanisms of oncogenesis. Am J Pathol. 2019;189(6):1122\u201332.","journal-title":"Am J Pathol"},{"issue":"1","key":"655_CR180","first-page":"27","volume":"38","author":"C Cheng","year":"2018","unstructured":"Cheng C, Geng F, Cheng X, Guo D. Lipid metabolism reprogramming and its potential targets in cancer. Cancer Commun (Lond). 2018;38(1):27.","journal-title":"Cancer Commun (Lond)"},{"key":"655_CR181","doi-asserted-by":"publisher","first-page":"581863","DOI":"10.3389\/fcell.2020.581863","volume":"8","author":"G Liu","year":"2020","unstructured":"Liu G, Liu G, Cui X, Xu Y. Transcriptomic data analyses reveal a reprogramed lipid metabolism in HCV-Derived hepatocellular Cancer. Front Cell Dev Biol. 2020;8:581863.","journal-title":"Front Cell Dev Biol"},{"key":"655_CR182","doi-asserted-by":"publisher","first-page":"605302","DOI":"10.1155\/2012\/605302","volume":"2012","author":"F Agriesti","year":"2012","unstructured":"Agriesti F, Tataranni T, Ruggieri V, Capitanio N, Piccoli C. PPARs and HCV-Related hepatocarcinoma: A mitochondrial point of view. PPAR Res. 2012;2012:605302.","journal-title":"PPAR Res"},{"issue":"7","key":"655_CR183","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.bbadis.2014.03.015","volume":"1842","author":"W Shen","year":"2014","unstructured":"Shen W, Gao Y, Lu B, Zhang Q, Hu Y, Chen Y. Negatively regulating TLR4\/NF-\u03baB signaling via PPAR\u03b1 in endotoxin-induced uveitis. Biochim Biophys Acta. 2014;1842(7):1109\u201320.","journal-title":"Biochim Biophys Acta"},{"issue":"24","key":"655_CR184","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1182\/blood-2017-11-817601","volume":"131","author":"W Ren","year":"2018","unstructured":"Ren W, Ye X, Su H, Li W, Liu D, Pirmoradian M, et al. Genetic landscape of hepatitis B virus-associated diffuse large B-cell lymphoma. Blood. 2018;131(24):2670\u201381.","journal-title":"Blood"},{"key":"655_CR185","doi-asserted-by":"crossref","unstructured":"Foka P, Dimitriadis A, Karamichali E, Kochlios E, Eliadis P, Valiakou V et al. HCV-Induced immunometabolic crosstalk in a Triple-Cell Co-Culture model capable of simulating systemic Iron homeostasis. Cells. 2021;10(9).","DOI":"10.3390\/cells10092251"},{"key":"655_CR186","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.canlet.2019.03.015","volume":"452","author":"S Wang","year":"2019","unstructured":"Wang S, Liu R, Yu Q, Dong L, Bi Y, Liu G. Metabolic reprogramming of macrophages during infections and cancer. Cancer Lett. 2019;452:14\u201322.","journal-title":"Cancer Lett"},{"key":"655_CR187","doi-asserted-by":"crossref","unstructured":"Herbein G. The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses. 2018;10(8).","DOI":"10.3390\/v10080408"},{"key":"655_CR188","doi-asserted-by":"crossref","unstructured":"Herbein G. High-Risk Oncogenic Human Cytomegalovirus. Viruses. 2022;14(11).","DOI":"10.3390\/v14112462"},{"issue":"7","key":"655_CR189","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1038\/s41417-024-00767-7","volume":"31","author":"J Guyon","year":"2024","unstructured":"Guyon J, Haidar Ahmad S, El Baba R, Le Quang M, Bikfalvi A, Daubon T, et al. Generation of glioblastoma in mice engrafted with human cytomegalovirus-infected astrocytes. Cancer Gene Ther. 2024;31(7):1070\u201380.","journal-title":"Cancer Gene Ther"},{"issue":"24","key":"655_CR190","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1038\/s41388-023-02709-3","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Monnien F, Abad M, Bibeau F, et al. EZH2-Myc driven glioblastoma elicited by cytomegalovirus infection of human astrocytes. Oncogene. 2023;42(24):2031\u201345.","journal-title":"Oncogene"},{"key":"655_CR191","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ebiom.2018.03.015","volume":"30","author":"A Kumar","year":"2018","unstructured":"Kumar A, Tripathy MK, Pasquereau S, Al Moussawi F, Abbas W, Coquard L, et al. The human cytomegalovirus strain DB activates oncogenic pathways in mammary epithelial cells. EBioMedicine. 2018;30:167\u201383.","journal-title":"EBioMedicine"},{"issue":"41","key":"655_CR192","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1038\/s41388-023-02813-4","volume":"42","author":"R El Baba","year":"2023","unstructured":"El Baba R, Haidar Ahmad S, Monnien F, Mansar R, Bibeau F, Herbein G, Polyploidy. EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells. Oncogene. 2023;42(41):3047\u201361.","journal-title":"Oncogene"},{"key":"655_CR193","doi-asserted-by":"crossref","unstructured":"Bouezzedine F, El Baba R, Haidar Ahmad S, Herbein G. Polyploid giant Cancer cells generated from human Cytomegalovirus-Infected prostate epithelial cells. Cancers (Basel). 2023;15(20).","DOI":"10.3390\/cancers15204994"},{"key":"655_CR194","doi-asserted-by":"crossref","unstructured":"El Baba R, Pasquereau S, Haidar Ahmad S, Diab-Assaf M, Herbein G. Oncogenic and stemness signatures of the High-Risk HCMV strains in breast Cancer progression. Cancers (Basel). 2022;14(17).","DOI":"10.3390\/cancers14174271"},{"key":"655_CR195","doi-asserted-by":"publisher","first-page":"1321116","DOI":"10.3389\/fmicb.2023.1321116","volume":"14","author":"C Gourin","year":"2023","unstructured":"Gourin C, Alain S, Hantz S. Anti-CMV therapy, what next? A systematic review. Front Microbiol. 2023;14:1321116.","journal-title":"Front Microbiol"},{"key":"655_CR196","doi-asserted-by":"publisher","first-page":"101430","DOI":"10.1016\/j.smim.2020.101430","volume":"50","author":"E Sasso","year":"2020","unstructured":"Sasso E, D\u2019Alise AM, Zambrano N, Scarselli E, Folgori A, Nicosia A. New viral vectors for infectious diseases and cancer. Semin Immunol. 2020;50:101430.","journal-title":"Semin Immunol"},{"issue":"3","key":"655_CR197","first-page":"173","volume":"7","author":"I Dedinsk\u00e1","year":"2016","unstructured":"Dedinsk\u00e1 I, Laca \u013d, Miklu\u0161ica J, Kant\u00e1rov\u00e1 D, Galajda P, Mok\u00e1\u0148 M. Correlation between CMV infection and Post-transplantation New-onset diabetes mellitus. Int J Organ Transplantation Med. 2016;7(3):173\u201382.","journal-title":"Int J Organ Transplantation Med"},{"issue":"1","key":"655_CR198","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/pedi.12788","volume":"20","author":"I Ekman","year":"2019","unstructured":"Ekman I, Vuorinen T, Knip M, Veijola R, Toppari J, Hy\u00f6ty H, et al. Early childhood CMV infection May decelerate the progression to clinical type 1 diabetes. Pediatr Diabetes. 2019;20(1):73\u20137.","journal-title":"Pediatr Diabetes"},{"key":"655_CR199","first-page":"30","volume-title":"Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study","author":"MB Haeseker","year":"2013","unstructured":"Haeseker MB, Pijpers E, Dukers-Muijrers NH, Nelemans P, Hoebe CJ, Bruggeman CA, et al. Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study. Volume 10. Immunity & ageing: I & A; 2013. p. 30. 1."},{"issue":"6","key":"655_CR200","doi-asserted-by":"publisher","first-page":"815","DOI":"10.4093\/dmj.2018.0167","volume":"43","author":"SG Yoo","year":"2019","unstructured":"Yoo SG, Han KD, Lee KH, La Y, Kwon DE, Han SH. Impact of cytomegalovirus disease on New-Onset type 2 diabetes mellitus: Population-Based matched Case-Control cohort study. Diabetes Metabolism J. 2019;43(6):815\u201329.","journal-title":"Diabetes Metabolism J"},{"issue":"6033","key":"655_CR201","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1126\/science.1202007","volume":"332","author":"JY Seo","year":"2011","unstructured":"Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein Viperin to enhance infectivity. Science. 2011;332(6033):1093\u20137.","journal-title":"Science"},{"issue":"8","key":"655_CR202","doi-asserted-by":"publisher","first-page":"e1003497","DOI":"10.1371\/journal.ppat.1003497","volume":"9","author":"JY Seo","year":"2013","unstructured":"Seo JY, Cresswell P. Viperin regulates cellular lipid metabolism during human cytomegalovirus infection. PLoS Pathog. 2013;9(8):e1003497.","journal-title":"PLoS Pathog"},{"issue":"12","key":"655_CR203","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1182\/blood-2016-07-723148","volume":"129","author":"SS Francis","year":"2017","unstructured":"Francis SS, Wallace AD, Wendt GA, Li L, Liu F, Riley LW, et al. In utero cytomegalovirus infection and development of childhood acute lymphoblastic leukemia. Blood. 2017;129(12):1680\u20134.","journal-title":"Blood"},{"key":"655_CR204","doi-asserted-by":"crossref","unstructured":"El Baba R, Herbein G. EZH2-Myc Hallmark in Oncovirus\/Cytomegalovirus Infections and Cytomegalovirus\u2019 Resemblance to Oncoviruses. Cells. 2024;13(6).","DOI":"10.3390\/cells13060541"},{"key":"655_CR205","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1479-5876-9-44","volume":"9","author":"B Salaun","year":"2011","unstructured":"Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, et al. Differentiation associated regulation of MicroRNA expression in vivo in human CD8+ T cell subsets. J Transl Med. 2011;9:44.","journal-title":"J Transl Med"},{"issue":"2","key":"655_CR206","doi-asserted-by":"publisher","first-page":"205","DOI":"10.5507\/bp.2006.029","volume":"150","author":"B Kusenda","year":"2006","unstructured":"Kusenda B, Mraz M, Mayer J, Pospisilova S. MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2006;150(2):205\u201315.","journal-title":"Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub"},{"issue":"2","key":"655_CR207","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1182\/blood-2008-07-163907","volume":"113","author":"M Inomata","year":"2009","unstructured":"Inomata M, Tagawa H, Guo YM, Kameoka Y, Takahashi N, Sawada K. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood. 2009;113(2):396\u2013402.","journal-title":"Blood"},{"issue":"11","key":"655_CR208","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/labinvest.2012.129","volume":"92","author":"A Fassina","year":"2012","unstructured":"Fassina A, Marino F, Siri M, Zambello R, Ventura L, Fassan M, et al. The miR-17-92 MicroRNA cluster: a novel diagnostic tool in large B-cell malignancies. Lab Invest. 2012;92(11):1574\u201382.","journal-title":"Lab Invest"},{"issue":"2","key":"655_CR209","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1203\/01.PDR.0000104150.85437.FE","volume":"55","author":"MA Elbou Ould","year":"2004","unstructured":"Elbou Ould MA, Luton D, Yadini M, Pedron B, Aujard Y, Jacqz-Aigrain E, et al. Cellular immune response of fetuses to cytomegalovirus. Pediatr Res. 2004;55(2):280\u20136.","journal-title":"Pediatr Res"},{"issue":"4","key":"655_CR210","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1084\/jem.20090348","volume":"207","author":"D Vermijlen","year":"2010","unstructured":"Vermijlen D, Brouwer M, Donner C, Liesnard C, Tackoen M, Van Rysselberge M, et al. Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. J Exp Med. 2010;207(4):807\u201321.","journal-title":"J Exp Med"},{"key":"655_CR211","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.coviro.2020.07.013","volume":"44","author":"EC Semmes","year":"2020","unstructured":"Semmes EC, Hurst JH, Walsh KM, Permar SR. Cytomegalovirus as an Immunomodulator across the lifespan. Curr Opin Virol. 2020;44:112\u201320.","journal-title":"Curr Opin Virol"},{"issue":"1","key":"655_CR212","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4049\/jimmunol.1601182","volume":"198","author":"R Rovito","year":"2017","unstructured":"Rovito R, Korndewal MJ, van Zelm MC, Ziagkos D, van der Wessels E, et al. T and B cell markers in dried blood spots of neonates with congenital cytomegalovirus infection: B cell numbers at birth are associated with Long-Term outcomes. J Immunol. 2017;198(1):102\u20139.","journal-title":"J Immunol"},{"issue":"1","key":"655_CR213","doi-asserted-by":"publisher","first-page":"3548","DOI":"10.1038\/s41467-020-17178-5","volume":"11","author":"CP Ouellette","year":"2020","unstructured":"Ouellette CP, S\u00e1nchez PJ, Xu Z, Blankenship D, Zeray F, Ronchi A, et al. Blood genome expression profiles in infants with congenital cytomegalovirus infection. Nat Commun. 2020;11(1):3548.","journal-title":"Nat Commun"},{"issue":"5","key":"655_CR214","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/S0092-8674(00)81054-5","volume":"84","author":"EJ Wiertz","year":"1996","unstructured":"Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, Ploegh HL. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the Endoplasmic reticulum to the cytosol. Cell. 1996;84(5):769\u201379.","journal-title":"Cell"},{"key":"655_CR215","first-page":"333","volume":"325","author":"C Powers","year":"2008","unstructured":"Powers C, DeFilippis V, Malouli D, Fr\u00fch K. Cytomegalovirus immune evasion. Curr Top Microbiol Immunol. 2008;325:333\u201359.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"6","key":"655_CR216","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00281-014-0448-2","volume":"36","author":"E Corrales-Aguilar","year":"2014","unstructured":"Corrales-Aguilar E, Hoffmann K, Hengel H. CMV-encoded Fc\u03b3 receptors: modulators at the interface of innate and adaptive immunity. Semin Immunopathol. 2014;36(6):627\u201340.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"655_CR217","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/ijc.34292","volume":"152","author":"RE Gallant","year":"2023","unstructured":"Gallant RE, Arroyo K, Metayer C, Kang AY, de Smith AJ, Wiemels JL. Associations between early-life and in utero infections and cytomegalovirus-positive acute lymphoblastic leukemia in children. Int J Cancer. 2023;152(5):845\u201353.","journal-title":"Int J Cancer"},{"issue":"4","key":"655_CR218","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s11864-022-00963-3","volume":"23","author":"N R\u00fcchel","year":"2022","unstructured":"R\u00fcchel N, Jepsen VH, Hein D, Fischer U, Borkhardt A, G\u00f6ssling KL. In utero development and immunosurveillance of B cell acute lymphoblastic leukemia. Curr Treat Options Oncol. 2022;23(4):543\u201361.","journal-title":"Curr Treat Options Oncol"},{"issue":"18","key":"655_CR219","doi-asserted-by":"publisher","first-page":"5458","DOI":"10.1158\/0008-5472.CAN-18-0831","volume":"78","author":"SH S\u00f8egaard","year":"2018","unstructured":"S\u00f8egaard SH, Rostgaard K, Skogstrand K, Wiemels JL, Schmiegelow K, Hjalgrim H. Neonatal inflammatory markers are associated with childhood B-cell precursor acute lymphoblastic leukemia. Cancer Res. 2018;78(18):5458\u201363.","journal-title":"Cancer Res"},{"issue":"9","key":"655_CR220","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.3324\/haematol.2022.280826","volume":"107","author":"JL Wiemels","year":"2022","unstructured":"Wiemels JL, Wang R, Zhou M, Hansen H, Gallant R, Jung J, et al. Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children. Haematologica. 2022;107(9):2266\u201370.","journal-title":"Haematologica"},{"key":"655_CR221","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fimmu.2014.00552","volume":"5","author":"A Huygens","year":"2014","unstructured":"Huygens A, Dauby N, Vermijlen D, Marchant A. Immunity to cytomegalovirus in early life. Front Immunol. 2014;5:552.","journal-title":"Front Immunol"},{"key":"655_CR222","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2018.03.015","volume":"192","author":"MA Moro-Garc\u00eda","year":"2018","unstructured":"Moro-Garc\u00eda MA, L\u00f3pez-Iglesias F, Marcos-Fern\u00e1ndez R, Bueno-Garc\u00eda E, D\u00edaz-Molina B, Lambert JL, et al. More intensive CMV-infection in chronic heart failure patients contributes to higher T-lymphocyte differentiation degree. Clin Immunol. 2018;192:20\u20139.","journal-title":"Clin Immunol"},{"key":"655_CR223","doi-asserted-by":"publisher","first-page":"703256","DOI":"10.3389\/fimmu.2021.703256","volume":"12","author":"S Alonso-\u00c1lvarez","year":"2021","unstructured":"Alonso-\u00c1lvarez S, Colado E, Moro-Garc\u00eda MA, Alonso-Arias R. Cytomegalovirus in haematological tumours. Front Immunol. 2021;12:703256.","journal-title":"Front Immunol"},{"issue":"5866","key":"655_CR224","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.1152586","volume":"319","author":"H Feng","year":"2008","unstructured":"Feng H, Shuda M, Chang Y, Moore PS. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science. 2008;319(5866):1096\u2013100.","journal-title":"Science"},{"issue":"20","key":"655_CR225","doi-asserted-by":"publisher","first-page":"11332","DOI":"10.1128\/JVI.00875-07","volume":"81","author":"H Feng","year":"2007","unstructured":"Feng H, Taylor JL, Benos PV, Newton R, Waddell K, Lucas SB, et al. Human transcriptome Subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol. 2007;81(20):11332\u201340.","journal-title":"J Virol"},{"issue":"1","key":"655_CR226","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.canep.2009.12.007","volume":"34","author":"V Koljonen","year":"2010","unstructured":"Koljonen V, Kukko H, Tukiainen E, B\u00f6hling T, Sankila R, Joensuu H, et al. Second cancers following the diagnosis of Merkel cell carcinoma: a nationwide cohort study. Cancer Epidemiol. 2010;34(1):62\u20135.","journal-title":"Cancer Epidemiol"},{"issue":"5","key":"655_CR227","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/nrc798","volume":"2","author":"H zur Hausen","year":"2002","unstructured":"zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer. 2002;2(5):342\u201350.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"655_CR228","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/CMR.16.1.1-17.2003","volume":"16","author":"EM Burd","year":"2003","unstructured":"Burd EM. Human papillomavirus and cervical cancer. Clin Microbiol Rev. 2003;16(1):1\u201317.","journal-title":"Clin Microbiol Rev"},{"key":"655_CR229","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2013.09.004","volume":"4","author":"GB Melikyan","year":"2014","unstructured":"Melikyan GB. HIV entry: a game of hide-and-fuse? Curr Opin Virol. 2014;4:1\u20137.","journal-title":"Curr Opin Virol"},{"key":"655_CR230","unstructured":"Human Immunodeficiency Virus (HIV). Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie. 2016;43(3):203-22."},{"key":"655_CR231","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/978-94-007-2869-1_7","volume":"942","author":"J Estaquier","year":"2012","unstructured":"Estaquier J, Vallette F, Vayssiere JL, Mignotte B. The mitochondrial pathways of apoptosis. Adv Exp Med Biol. 2012;942:157\u201383.","journal-title":"Adv Exp Med Biol"},{"issue":"11","key":"655_CR232","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/sj.cdd.4401289","volume":"10","author":"D Arnoult","year":"2003","unstructured":"Arnoult D, Petit F, Leli\u00e8vre JD, Lecossier D, Hance A, Monceaux V, et al. Caspase-dependent and -independent T-cell death pathways in pathogenic Simian immunodeficiency virus infection: relationship to disease progression. Cell Death Differ. 2003;10(11):1240\u201352.","journal-title":"Cell Death Differ"},{"issue":"6","key":"655_CR233","doi-asserted-by":"publisher","first-page":"3299","DOI":"10.4049\/jimmunol.1003613","volume":"186","author":"RD Michalek","year":"2011","unstructured":"Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186(6):3299\u2013303.","journal-title":"J Immunol"},{"key":"655_CR234","doi-asserted-by":"crossref","unstructured":"Valent\u00edn-Guillama G, L\u00f3pez S, Kucheryavykh YV, Chorna NE, P\u00e9rez J, Ortiz-Rivera J et al. HIV-1 envelope protein gp120 promotes proliferation and the activation of Glycolysis in glioma cell. Cancers (Basel). 2018;10(9).","DOI":"10.3390\/cancers10090301"},{"issue":"3191","key":"655_CR235","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309\u201314.","journal-title":"Science"},{"issue":"11","key":"655_CR236","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4(11):891\u20139.","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"655_CR237","first-page":"163","volume":"39","author":"P Mazzuca","year":"2016","unstructured":"Mazzuca P, Caruso A, Caccuri F. HIV-1 infection, microenvironment and endothelial cell dysfunction. New Microbiol. 2016;39(3):163\u201373.","journal-title":"New Microbiol"},{"issue":"10","key":"655_CR238","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.devcel.2021.03.034","volume":"56","author":"AS Mutlu","year":"2021","unstructured":"Mutlu AS, Duffy J, Wang MC. Lipid metabolism and lipid signals in aging and longevity. Dev Cell. 2021;56(10):1394\u2013407.","journal-title":"Dev Cell"},{"key":"655_CR239","doi-asserted-by":"publisher","first-page":"6634532","DOI":"10.1155\/2021\/6634532","volume":"2021","author":"F Cai","year":"2021","unstructured":"Cai F, Jin S, Chen G. The effect of lipid metabolism on CD4(+) T cells. Mediators Inflamm. 2021;2021:6634532.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"655_CR240","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41572-020-0181-1","volume":"6","author":"JR Koethe","year":"2020","unstructured":"Koethe JR, Lagathu C, Lake JE, Domingo P, Calmy A, Falutz J, et al. HIV and antiretroviral therapy-related fat alterations. Nat Rev Dis Primers. 2020;6(1):48.","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"655_CR241","doi-asserted-by":"publisher","first-page":"e3003","DOI":"10.1371\/journal.pone.0003003","volume":"3","author":"S Rasheed","year":"2008","unstructured":"Rasheed S, Yan JS, Lau A, Chan AS. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS ONE. 2008;3(8):e3003.","journal-title":"PLoS ONE"},{"key":"655_CR242","doi-asserted-by":"crossref","unstructured":"Deme P, Rubin LH, Yu D, Xu Y, Nakigozi G, Nakasujja N et al. Immunometabolic reprogramming in response to HIV infection is not fully normalized by suppressive antiretroviral therapy. Viruses. 2022;14(6).","DOI":"10.3390\/v14061313"},{"issue":"2","key":"655_CR243","doi-asserted-by":"publisher","first-page":"100205","DOI":"10.1016\/j.xcrm.2021.100205","volume":"2","author":"CN Wanjalla","year":"2021","unstructured":"Wanjalla CN, McDonnell WJ, Ram R, Chopra A, Gangula R, Leary S, et al. Single-cell analysis shows that adipose tissue of persons with both HIV and diabetes is enriched for clonal, cytotoxic, and CMV-specific CD4+ T cells. Cell Rep Med. 2021;2(2):100205.","journal-title":"Cell Rep Med"},{"issue":"10","key":"655_CR244","doi-asserted-by":"publisher","first-page":"e78146","DOI":"10.1371\/journal.pone.0078146","volume":"8","author":"MA Jenabian","year":"2013","unstructured":"Jenabian MA, Patel M, Kema I, Kanagaratham C, Radzioch D, Th\u00e9bault P, et al. Distinct Tryptophan catabolism and Th17\/Treg balance in HIV progressors and elite controllers. PLoS ONE. 2013;8(10):e78146.","journal-title":"PLoS ONE"},{"issue":"8","key":"655_CR245","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cid\/ciy676","volume":"68","author":"J Chen","year":"2019","unstructured":"Chen J, Xun J, Yang J, Ji Y, Liu L, Qi T, et al. Plasma indoleamine 2,3-Dioxygenase activity is associated with the size of the human immunodeficiency virus reservoir in patients receiving antiretroviral therapy. Clin Infect Dis. 2019;68(8):1274\u201381.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"655_CR246","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0021-9258(19)85901-X","volume":"255","author":"S Bannai","year":"1980","unstructured":"Bannai S, Kitamura E. Transport interaction of L-cystine and L-glutamate in human diploid fibroblasts in culture. J Biol Chem. 1980;255(6):2372\u20136.","journal-title":"J Biol Chem"},{"issue":"5","key":"655_CR247","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1016\/S0021-9258(17)35926-4","volume":"261","author":"S Bannai","year":"1986","unstructured":"Bannai S. Exchange of cystine and glutamate across plasma membrane of human fibroblasts. J Biol Chem. 1986;261(5):2256\u201363.","journal-title":"J Biol Chem"},{"issue":"6","key":"655_CR248","doi-asserted-by":"publisher","first-page":"e1000495","DOI":"10.1371\/journal.ppat.1000495","volume":"5","author":"SE Kauder","year":"2009","unstructured":"Kauder SE, Bosque A, Lindqvist A, Planelles V, Verdin E. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 2009;5(6):e1000495.","journal-title":"PLoS Pathog"},{"issue":"20","key":"655_CR249","doi-asserted-by":"publisher","first-page":"9753","DOI":"10.1128\/JVI.75.20.9753-9761.2001","volume":"75","author":"JY Fang","year":"2001","unstructured":"Fang JY, Mikovits JA, Bagni R, Petrow-Sadowski CL, Ruscetti FW. Infection of lymphoid cells by integration-defective human immunodeficiency virus type 1 increases de Novo methylation. J Virol. 2001;75(20):9753\u201361.","journal-title":"J Virol"},{"issue":"5","key":"655_CR250","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1128\/MCB.18.5.2535","volume":"18","author":"A El Kharroubi","year":"1998","unstructured":"El Kharroubi A, Piras G, Zensen R, Martin MA. Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter. Mol Cell Biol. 1998;18(5):2535\u201344.","journal-title":"Mol Cell Biol"},{"issue":"8","key":"655_CR251","doi-asserted-by":"publisher","first-page":"e1000554","DOI":"10.1371\/journal.ppat.1000554","volume":"5","author":"J Blazkova","year":"2009","unstructured":"Blazkova J, Trejbalova K, Gondois-Rey F, Halfon P, Philibert P, Guiguen A, et al. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 2009;5(8):e1000554.","journal-title":"PLoS Pathog"},{"issue":"3","key":"655_CR252","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.chom.2008.02.002","volume":"3","author":"HS Kwon","year":"2008","unstructured":"Kwon HS, Brent MM, Getachew R, Jayakumar P, Chen LF, Schnolzer M, et al. Human immunodeficiency virus type 1 Tat protein inhibits the SIRT1 deacetylase and induces T cell hyperactivation. Cell Host Microbe. 2008;3(3):158\u201367.","journal-title":"Cell Host Microbe"},{"issue":"4","key":"655_CR253","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/QAD.0000000000000120","volume":"28","author":"A Matsunaga","year":"2014","unstructured":"Matsunaga A, Hishima T, Tanaka N, Yamasaki M, Yoshida L, Mochizuki M, et al. DNA methylation profiling can classify HIV-associated lymphomas. Aids. 2014;28(4):503\u201310.","journal-title":"Aids"},{"issue":"8","key":"655_CR254","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1039\/c2ib20034a","volume":"4","author":"S Saha","year":"2012","unstructured":"Saha S, Lo PK, Duan X, Chen H, Wang Q. Breast tumour initiating cell fate is regulated by microenvironmental cues from an extracellular matrix. Integr Biol (Camb). 2012;4(8):897\u2013904.","journal-title":"Integr Biol (Camb)"},{"issue":"7","key":"655_CR255","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.tiv.2013.07.011","volume":"27","author":"RC Montenegro","year":"2013","unstructured":"Montenegro RC, de Vasconcellos MC, Barbosa Gdos S, Burbano RM, Souza LG, Lemos TL, et al. A novel o-naphtoquinone inhibits N-cadherin expression and blocks melanoma cell invasion via AKT signaling. Toxicol Vitro. 2013;27(7):2076\u201383.","journal-title":"Toxicol Vitro"},{"issue":"3","key":"655_CR256","first-page":"601","volume":"18","author":"T Ando","year":"2007","unstructured":"Ando T, Ishiguro H, Kimura M, Mitsui A, Mori Y, Sugito N, et al. The overexpression of caveolin-1 and caveolin-2 correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma. Oncol Rep. 2007;18(3):601\u20139.","journal-title":"Oncol Rep"},{"issue":"2","key":"655_CR257","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","volume":"29","author":"S Casimiro","year":"2012","unstructured":"Casimiro S, Luis I, Fernandes A, Pires R, Pinto A, Gouveia AG, et al. Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors. Clin Exp Metastasis. 2012;29(2):155\u201364.","journal-title":"Clin Exp Metastasis"},{"issue":"12","key":"655_CR258","doi-asserted-by":"publisher","first-page":"3712","DOI":"10.1182\/blood.V96.12.3712","volume":"96","author":"P Salven","year":"2000","unstructured":"Salven P, Orpana A, Teerenhovi L, Joensuu H. Simultaneous elevation in the serum concentrations of the angiogenic growth factors VEGF and bFGF is an independent predictor of poor prognosis in non-Hodgkin lymphoma: a single-institution study of 200 patients. Blood. 2000;96(12):3712\u20138.","journal-title":"Blood"},{"issue":"3","key":"655_CR259","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2014.07.022","volume":"427","author":"M Lusic","year":"2015","unstructured":"Lusic M, Giacca M. Regulation of HIV-1 latency by chromatin structure and nuclear architecture. J Mol Biol. 2015;427(3):688\u201394.","journal-title":"J Mol Biol"},{"key":"655_CR260","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3389\/fphar.2017.00876","volume":"8","author":"L Zhou","year":"2017","unstructured":"Zhou L, Tang J, Xiong X, Dong H, Huang J, Zhou S, et al. Psoralea corylifolia L. Attenuates nonalcoholic steatohepatitis in juvenile mouse. Front Pharmacol. 2017;8:876.","journal-title":"Front Pharmacol"},{"key":"655_CR261","doi-asserted-by":"crossref","unstructured":"Ramorola BR, Goolam-Hoosen T, Alves de Souza Rios L, Mowla S. Modulation of cellular MicroRNA by HIV-1 in Burkitt lymphoma Cells-A pathway to promoting oncogenesis. Genes (Basel). 2021;12(9).","DOI":"10.3390\/genes12091302"},{"issue":"9","key":"655_CR262","doi-asserted-by":"publisher","first-page":"8387","DOI":"10.1007\/s13277-014-2068-9","volume":"35","author":"D Sekar","year":"2014","unstructured":"Sekar D, Hairul Islam VI, Thirugnanasambantham K, Saravanan S. Relevance of miR-21 in HIV and non-HIV-related lymphomas. Tumour Biol. 2014;35(9):8387\u201393.","journal-title":"Tumour Biol"},{"issue":"3","key":"655_CR263","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.leukres.2014.12.002","volume":"39","author":"LS Danielson","year":"2015","unstructured":"Danielson LS, Reavie L, Coussens M, Davalos V, Castillo-Martin M, Guijarro MV, et al. Limited miR-17-92 overexpression drives hematologic malignancies. Leuk Res. 2015;39(3):335\u201341.","journal-title":"Leuk Res"},{"issue":"2","key":"655_CR264","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.ccr.2014.06.014","volume":"26","author":"Y Li","year":"2014","unstructured":"Li Y, Choi PS, Casey SC, Dill DL, Felsher DW. MYC through miR-17-92 suppresses specific target genes to maintain survival, autonomous proliferation, and a neoplastic state. Cancer Cell. 2014;26(2):262\u201372.","journal-title":"Cancer Cell"},{"issue":"6","key":"655_CR265","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1111\/j.1365-2141.2007.06611.x","volume":"137","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH. MicroRNAs and haematology: small molecules, big function. Br J Haematol. 2007;137(6):503\u201312.","journal-title":"Br J Haematol"},{"issue":"9","key":"655_CR266","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1517\/14712598.7.9.1363","volume":"7","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH. MicroRNA expression in lymphoma. Expert Opin Biol Ther. 2007;7(9):1363\u201374.","journal-title":"Expert Opin Biol Ther"},{"issue":"5","key":"655_CR267","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1002\/ijc.22800","volume":"121","author":"CH Lawrie","year":"2007","unstructured":"Lawrie CH, Soneji S, Marafioti T, Cooper CD, Palazzo S, Paterson JC, et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int J Cancer. 2007;121(5):1156\u201361.","journal-title":"Int J Cancer"},{"issue":"5","key":"655_CR268","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1182\/blood-2007-06-096784","volume":"111","author":"A Navarro","year":"2008","unstructured":"Navarro A, Gaya A, Martinez A, Urbano-Ispizua A, Pons A, Balagu\u00e9 O, et al. MicroRNA expression profiling in classic hodgkin lymphoma. Blood. 2008;111(5):2825\u201332.","journal-title":"Blood"},{"issue":"5","key":"655_CR269","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3109\/10408363.2015.1030063","volume":"52","author":"R Grewal","year":"2015","unstructured":"Grewal R, Cucuianu A, Swanepoel C, Dima D, Petrushev B, Pop B, et al. The role of MicroRNAs in the pathogenesis of HIV-related lymphomas. Crit Rev Clin Lab Sci. 2015;52(5):232\u201341.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"5","key":"655_CR270","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1128\/jvi.71.5.4016-4023.1997","volume":"71","author":"SV Joag","year":"1997","unstructured":"Joag SV, Adany I, Li Z, Foresman L, Pinson DM, Wang C, et al. Animal model of mucosally transmitted human immunodeficiency virus type 1 disease: intravaginal and oral deposition of Simian\/human immunodeficiency virus in macaques results in systemic infection, elimination of CD4+ T cells, and AIDS. J Virol. 1997;71(5):4016\u201323.","journal-title":"J Virol"},{"issue":"13","key":"655_CR271","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1097\/00002030-199713000-00003","volume":"11","author":"ML Bosch","year":"1997","unstructured":"Bosch ML, Schmidt A, Agy MB, Kimball LE, Morton WR. Infection of Macaca nemestrina neonates with HIV-1 via different routes of inoculation. Aids. 1997;11(13):1555\u201363.","journal-title":"Aids"},{"issue":"21","key":"655_CR272","doi-asserted-by":"publisher","first-page":"11388","DOI":"10.1128\/JVI.01377-13","volume":"87","author":"AM Carias","year":"2013","unstructured":"Carias AM, McCoombe S, McRaven M, Anderson M, Galloway N, Vandergrift N, et al. Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol. 2013;87(21):11388\u2013400.","journal-title":"J Virol"},{"issue":"15","key":"655_CR273","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1089\/aid.1998.14.1357","volume":"14","author":"M Girard","year":"1998","unstructured":"Girard M, Mahoney J, van der Wei Q, Muchmore E, Barr\u00e9-Sinoussi F, et al. Genital infection of female chimpanzees with human immunodeficiency virus type 1. AIDS Res Hum Retroviruses. 1998;14(15):1357\u201367.","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"3","key":"655_CR274","doi-asserted-by":"publisher","first-page":"e0149679","DOI":"10.1371\/journal.pone.0149679","volume":"11","author":"KA Brune","year":"2016","unstructured":"Brune KA, Ferreira F, Mandke P, Chau E, Aggarwal NR, D\u2019Alessio FR, et al. HIV impairs lung epithelial integrity and enters the epithelium to promote chronic lung inflammation. PLoS ONE. 2016;11(3):e0149679.","journal-title":"PLoS ONE"},{"issue":"5","key":"655_CR275","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/mi.2010.32","volume":"3","author":"Y Ganor","year":"2010","unstructured":"Ganor Y, Zhou Z, Tudor D, Schmitt A, Vacher-Lavenu MC, Gibault L, et al. Within 1\u00a0h, HIV-1 uses viral synapses to enter efficiently the inner, but not outer, foreskin mucosa and engages Langerhans-T cell conjugates. Mucosal Immunol. 2010;3(5):506\u201322.","journal-title":"Mucosal Immunol"},{"issue":"2","key":"655_CR276","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.immuni.2007.01.007","volume":"26","author":"F Hladik","year":"2007","unstructured":"Hladik F, Sakchalathorn P, Ballweber L, Lentz G, Fialkow M, Eschenbach D, et al. Initial events in Establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity. 2007;26(2):257\u201370.","journal-title":"Immunity"},{"issue":"32","key":"655_CR277","doi-asserted-by":"publisher","first-page":"11504","DOI":"10.1073\/pnas.0500848102","volume":"102","author":"D Maher","year":"2005","unstructured":"Maher D, Wu X, Schacker T, Horbul J, Southern P. HIV binding, penetration, and primary infection in human cervicovaginal tissue. Proc Natl Acad Sci U S A. 2005;102(32):11504\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"655_CR278","doi-asserted-by":"publisher","first-page":"e1002100","DOI":"10.1371\/journal.ppat.1002100","volume":"7","author":"Z Zhou","year":"2011","unstructured":"Zhou Z, Barry de Longchamps N, Schmitt A, Zerbib M, Vacher-Lavenu MC, Bomsel M, et al. HIV-1 efficient entry in inner foreskin is mediated by elevated CCL5\/RANTES that recruits T cells and fuels conjugate formation with Langerhans cells. PLoS Pathog. 2011;7(6):e1002100.","journal-title":"PLoS Pathog"},{"issue":"17","key":"655_CR279","doi-asserted-by":"publisher","first-page":"8596","DOI":"10.1128\/JVI.00744-09","volume":"83","author":"E Stoddard","year":"2009","unstructured":"Stoddard E, Ni H, Cannon G, Zhou C, Kallenbach N, Malamud D, et al. gp340 promotes transcytosis of human immunodeficiency virus type 1 in genital tract-derived cell lines and primary endocervical tissue. J Virol. 2009;83(17):8596\u2013603.","journal-title":"J Virol"},{"issue":"11","key":"655_CR280","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1093\/infdis\/jit362","volume":"208","author":"AM Micsenyi","year":"2013","unstructured":"Micsenyi AM, Zony C, Alvarez RA, Durham ND, Chen BK, Klotman ME. Postintegration HIV-1 infection of cervical epithelial cells mediates contact-dependent productive infection of T cells. J Infect Dis. 2013;208(11):1756\u201367.","journal-title":"J Infect Dis"},{"issue":"4","key":"655_CR281","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1161\/ATVBAHA.113.302478","volume":"34","author":"F Caccuri","year":"2014","unstructured":"Caccuri F, Rueckert C, Giagulli C, Schulze K, Basta D, Zicari S, et al. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1\/endothelin B receptor axis. Arterioscler Thromb Vasc Biol. 2014;34(4):846\u201356.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"655_CR282","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.3389\/fimmu.2019.01850","volume":"10","author":"O Lucar","year":"2019","unstructured":"Lucar O, Reeves RK, Jost S. A natural impact: NK cells at the intersection of Cancer and HIV disease. Front Immunol. 2019;10:1850.","journal-title":"Front Immunol"},{"issue":"4","key":"655_CR283","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1189\/jlb.0809564","volume":"87","author":"LC Huysentruyt","year":"2010","unstructured":"Huysentruyt LC, McGrath MS. The role of macrophages in the development and progression of AIDS-related non-Hodgkin lymphoma. J Leukoc Biol. 2010;87(4):627\u201332.","journal-title":"J Leukoc Biol"},{"issue":"3","key":"655_CR284","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2013-03-488171","volume":"122","author":"K Liapis","year":"2013","unstructured":"Liapis K, Clear A, Owen A, Coutinho R, Greaves P, Lee AM, et al. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies. Blood. 2013;122(3):424\u201333.","journal-title":"Blood"},{"issue":"7","key":"655_CR285","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1158\/1055-9965.EPI-11-0037","volume":"20","author":"EC Breen","year":"2011","unstructured":"Breen EC, Hussain SK, Magpantay L, Jacobson LP, Detels R, Rabkin CS, et al. B-cell stimulatory cytokines and markers of immune activation are elevated several years prior to the diagnosis of systemic AIDS-associated non-Hodgkin B-cell lymphoma. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1303\u201314.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"655_CR286","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41575-021-00570-x","volume":"19","author":"MH El-Sayed","year":"2022","unstructured":"El-Sayed MH, Feld JJ. Vaccination at the forefront of the fight against hepatitis B and C. Nat Rev Gastroenterol Hepatol. 2022;19(2):87\u20138.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"655_CR287","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2147\/ITT.S273327","volume":"9","author":"C Smalley Rumfield","year":"2020","unstructured":"Smalley Rumfield C, Roller N, Pellom ST, Schlom J, Jochems C. Therapeutic vaccines for HPV-Associated malignancies. Immunotargets Ther. 2020;9:167\u2013200.","journal-title":"Immunotargets Ther"},{"issue":"6","key":"655_CR288","doi-asserted-by":"publisher","first-page":"101587","DOI":"10.1016\/j.xcrm.2024.101587","volume":"5","author":"KR Edwards","year":"2024","unstructured":"Edwards KR, Schmidt K, Homad LJ, Kher GM, Xu G, Rodrigues KA, et al. Vaccination with nanoparticles displaying gH\/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Cell Rep Med. 2024;5(6):101587.","journal-title":"Cell Rep Med"},{"issue":"1","key":"655_CR289","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41541-022-00535-4","volume":"7","author":"C Casper","year":"2022","unstructured":"Casper C, Corey L, Cohen JI, Damania B, Gershon AA, Kaslow DC, et al. KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine. Npj Vaccines. 2022;7(1):108.","journal-title":"Npj Vaccines"},{"issue":"1","key":"655_CR290","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14760584.2023.2274482","volume":"22","author":"T Vesikari","year":"2023","unstructured":"Vesikari T, Langley JM, Popovic V, Diaz-Mitoma F. PreHevbrio: the first approved 3-antigen hepatitis B vaccine. Expert Rev Vaccines. 2023;22(1):1041\u201354.","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"655_CR291","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13046-023-02848-1","volume":"42","author":"G Wang","year":"2023","unstructured":"Wang G, Cao J, Gui M, Huang P, Zhang L, Qi R, et al. The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors. J Exp Clin Cancer Res. 2023;42(1):284.","journal-title":"J Exp Clin Cancer Res"},{"key":"655_CR292","doi-asserted-by":"publisher","first-page":"1038340","DOI":"10.3389\/fimmu.2022.1038340","volume":"13","author":"JA Minott","year":"2022","unstructured":"Minott JA, van Vloten JP, Yates JGE, Chan L, Wood GA, Viloria-Petit AM, et al. Multiplex flow cytometry-based assay for quantifying tumor- and virus-associated antibodies induced by immunotherapies. Front Immunol. 2022;13:1038340.","journal-title":"Front Immunol"},{"issue":"7","key":"655_CR293","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2221-1691(13)60106-9","volume":"3","author":"K Paydary","year":"2013","unstructured":"Paydary K, Khaghani P, Emamzadeh-Fard S, Alinaghi SA, Baesi K. The emergence of drug resistant HIV variants and novel anti-retroviral therapy. Asian Pac J Trop Biomed. 2013;3(7):515\u201322.","journal-title":"Asian Pac J Trop Biomed"},{"issue":"12","key":"655_CR294","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/v2122696","volume":"2","author":"S Margeridon-Thermet","year":"2010","unstructured":"Margeridon-Thermet S, Shafer RW. Comparison of the mechanisms of drug resistance among HIV, hepatitis B, and hepatitis C. Viruses. 2010;2(12):2696\u2013739.","journal-title":"Viruses"},{"issue":"1","key":"655_CR295","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/bjh.17142","volume":"192","author":"HH Huang","year":"2021","unstructured":"Huang HH, Hsiao FY, Chen HM, Wang CY, Ko BS. Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B-cell lymphoma in Taiwan - a population-based study. Br J Haematol. 2021;192(1):110\u20138.","journal-title":"Br J Haematol"},{"key":"655_CR296","doi-asserted-by":"publisher","first-page":"115713","DOI":"10.1016\/j.biopha.2023.115713","volume":"168","author":"Z Liu","year":"2023","unstructured":"Liu Z, Wang R, Wang Y, Duan Y, Zhan H. Targeting succinylation-mediated metabolic reprogramming as a potential approach for cancer therapy. Biomed pharmacotherapy = Biomedecine Pharmacotherapie. 2023;168:115713.","journal-title":"Biomed pharmacotherapy = Biomedecine Pharmacotherapie"},{"key":"655_CR297","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cellsig.2017.09.020","volume":"40","author":"M Granato","year":"2017","unstructured":"Granato M, Gilardini Montani MS, Romeo MA, Santarelli R, Gonnella R, D\u2019Orazi G, et al. Metformin triggers apoptosis in PEL cells and alters bortezomib-induced unfolded protein response increasing its cytotoxicity and inhibiting KSHV lytic cycle activation. Cell Signal. 2017;40:239\u201347.","journal-title":"Cell Signal"},{"issue":"4","key":"655_CR298","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1002\/cncr.29085","volume":"121","author":"JP Issa","year":"2015","unstructured":"Issa JP, Garcia-Manero G, Huang X, Cortes J, Ravandi F, Jabbour E, et al. Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia. Cancer. 2015;121(4):556\u201361.","journal-title":"Cancer"},{"issue":"2","key":"655_CR299","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/bjh.13016","volume":"167","author":"M Kirschbaum","year":"2014","unstructured":"Kirschbaum M, Gojo I, Goldberg SL, Bredeson C, Kujawski LA, Yang A, et al. A phase 1 clinical trial of Vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome. Br J Haematol. 2014;167(2):185\u201393.","journal-title":"Br J Haematol"},{"issue":"12","key":"655_CR300","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1158\/0008-5472.CAN-06-0080","volume":"66","author":"SD Gore","year":"2006","unstructured":"Gore SD, Baylin S, Sugar E, Carraway H, Miller CB, Carducci M, et al. Combined DNA methyltransferase and histone deacetylase Inhibition in the treatment of myeloid neoplasms. Cancer Res. 2006;66(12):6361\u20139.","journal-title":"Cancer Res"},{"key":"655_CR301","doi-asserted-by":"crossref","unstructured":"Iida S, Mine S, Ueda K, Suzuki T, Hasegawa H, Katano H. Suberoyl bis-hydroxamic acid reactivates Kaposi\u2019s sarcoma-associated herpesvirus through histone acetylation and induces apoptosis in lymphoma cells. J Virol. 2021;95(5).","DOI":"10.1128\/JVI.01785-20"},{"issue":"8","key":"655_CR302","doi-asserted-by":"publisher","first-page":"e23372","DOI":"10.1371\/journal.pone.0023372","volume":"6","author":"T Qin","year":"2011","unstructured":"Qin T, Castoro R, El Ahdab S, Jelinek J, Wang X, Si J, et al. Mechanisms of resistance to decitabine in the myelodysplastic syndrome. PLoS ONE. 2011;6(8):e23372.","journal-title":"PLoS ONE"},{"issue":"11","key":"655_CR303","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1158\/1078-0432.CCR-08-2196","volume":"15","author":"DJ Stewart","year":"2009","unstructured":"Stewart DJ, Issa JP, Kurzrock R, Nunez MI, Jelinek J, Hong D, et al. Decitabine effect on tumor global DNA methylation and other parameters in a phase I trial in refractory solid tumors and lymphomas. Clin Cancer Res. 2009;15(11):3881\u20138.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"655_CR304","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1158\/2159-8290.CD-11-0214","volume":"1","author":"RA Juergens","year":"2011","unstructured":"Juergens RA, Wrangle J, Vendetti FP, Murphy SC, Zhao M, Coleman B, et al. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer. Cancer Discov. 2011;1(7):598\u2013607.","journal-title":"Cancer Discov"},{"key":"655_CR305","doi-asserted-by":"crossref","unstructured":"Faria C, Gava F, Gravelle P, Valero JG, Doba\u00f1o-L\u00f3pez C, Van Acker N et al. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine. J Immunother Cancer. 2023;11(10).","DOI":"10.1136\/jitc-2023-007156"},{"issue":"11","key":"655_CR306","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1016\/j.chom.2023.09.011","volume":"31","author":"C Sun","year":"2023","unstructured":"Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, et al. A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV. Cell Host Microbe. 2023;31(11):1882\u2013e9710.","journal-title":"Cell Host Microbe"}],"container-title":["Experimental Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40164-025-00655-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40164-025-00655-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T08:03:45Z","timestamp":1746864225000},"score":1,"resource":{"primary":{"URL":"https:\/\/ehoonline.biomedcentral.com\/articles\/10.1186\/s40164-025-00655-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,10]]},"references-count":306,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["655"],"URL":"https:\/\/doi.org\/10.1186\/s40164-025-00655-2","relation":{},"ISSN":["2162-3619"],"issn-type":[{"value":"2162-3619","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,10]]},"assertion":[{"value":"6 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"69"}}